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The human microbiome has important roles in maintaining health, but dysbiosis 
of the microbiota can lead to disease. Polymicrobial interactions can result in synergy, 
producing disease that is worse than the sum of the respective single species infections. 
Despite this significant impact, synergy is understudied due to the complexity of 
polymicrobial interactions. Periodontitis is a microbiome-associated disease, and is one 
of the most common infectious diseases worldwide. Therefore, we have used periodontal 
disease as a model to study polymicrobial synergy. I have used two complementary 
approaches to study polymicrobial infections. The opportunistic periodontal pathogen 
Aggregatibacter actinomycetemcomitans exhibits synergy with streptococci in model 
murine infections. Because polymicrobial interactions are dependent on organisms’ 
abilities to sense their environments, I have examined the genetic regulatory mechanisms 
used by A. actinomycetemcomitans to interact with its environment. Through Northern 
blot analyses and biochemical approaches, I show that A. actinomycetemcomitans uses 
non-coding RNAs to regulate amino acid transport. Taking a comparative genomics 
approach, I demonstrate that A. actinomycetemcomitans DNA uptake systems are 
evolutionarily linked to genome defense. To describe host-influenced changes in gene 
expression, I develop a new technique to transcriptionally profile 
vii 
 
A. actinomycetemcomitans in a murine abscess infection, thereby revealing the 
importance of specific fermentative and anaerobic respiratory genes for in vivo survival. 
The long-term goal is to use these studies as a basis to characterize genetic regulatory 
mechanisms mediating synergy in polymicrobial A. actinomycetemcomitans infections 
with streptococci and other oral microbes. As a second approach to study polymicrobial 
infections, I analyze gene expression of healthy and diseased human plaque communities 
from aggressive periodontitis patients. Profiling ribosome content of healthy and diseased 
communities, I show that disease communities adopt similar less diverse population 
structures distinct from healthy populations. In addition to changes in population 
composition, using community transcriptional profiling I show that a keystone species 
within diseased communities up-regulates expression of genes involved in making the 
oral inflammatory molecule butyrate. These studies demonstrate for the first time that 
microbiome based diseases are marked by gene expression changes in addition to 
compositional changes. 
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Chapter 1. Introduction 
1.1 OVERVIEW 
The oral microbiome is composed of a complex bacterial population that plays 
important roles in health and disease [1]. Oral bacteria are important from both health and 
scientific perspectives. Oral diseases are the most prevalent diseases worldwide and 
represent significant healthcare burdens [2]. Additionally, the oral microbiome is an 
excellent system for studying microbial ecology, virulence, and evolution, because many 
oral bacteria are cultivable, and research has shown that complex interspecies metabolic 
and physical interactions mediate community structure [3]. 
 
Throughout my dissertation research I have used the oral microbiome to address 
questions related to microbial gene regulation, metabolism, evolution, ecology, and 
virulence. In this introductory chapter, I will provide a broad background about the oral 
microbiome, periodontal disease, and a major periodontal pathogen that has been the 
focus of most of my dissertation research. 
 
1.2 THE ORAL MICROBIOME AND PERIODONTITIS 
 
1.2.1 The oral microbiome 
Bacteria live throughout the human mouth, coating the tongue, buccal epithelium, 
teeth, and gums. Among these different environments, bacteria that reside in the 
subgingival crevice are of particular research interest due to their association with 
periodontal disease [1]. The subgingival crevice is the pocket between the tooth surface 
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and the gingival epithelium. Traditional culturing and metagenomic surveys of the 
subgingival crevice have revealed hundreds of species that populate this environment [4-
6], and changes in the population composition have been linked to disease [6]. 
 
The subgingival crevice is a dynamic environment that supports the growth of a 
diverse microbiota. Oxygen concentrations decrease with depth within the crevice [7]. 
This oxygen gradient allows obligate aerobes, facultative anaerobes, and obligate 
anaerobes to co-populate the crevice. Capillaries bathe the pocket in a nutrient-rich serum 
exudate, termed crevicular fluid, which contains sugars and proteins that microbes can 
break down and utilize for growth [8]. While gingival crevicular fluid promotes microbial 
growth, it also contains antimicrobial factors to prevent bacterial overgrowth [9, 10]. 
These factors include neutralizing antibodies, bactericidal host complement proteins, and 
immune phagocytic cells that survey the environment [9, 10]. As a result of these 
selective pressures, the periodontal microbiome has evolved to utilize nutrients and 
withstand host defenses present in gingival crevicular fluid. 
 
Highly evolved bacterial “specialists” dominate the subgingival crevice and most 
species are only found in this environment. Decades of research have revealed complex 
metabolic and physical interactions among microbes in the subgingival crevice [3]. 
Within this polymicrobial community, physical interactions promote the ordered 
development of multispecies surface-attached communities called biofilms [3]. Biofilm 
communities exhibit enhanced resistance to antimicrobial compounds and protect 
microbes from phagocytosis [11, 12], likely promoting community survival in the face of 
crevicular fluid antimicrobials and phagocytic cells. Bacteria are organized spatially 
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within biofilms [13], which may facilitate interspecies metabolic interactions [14-16]. 
Ultimately, these complex interactions dictate periodontal health, and imbalances in the 
population structure are highly correlated with periodontitis. 
 
1.2.2 Periodontal disease 
Periodontal disease affects greater than 10% of the world’s population at any 
given time [2], and it is estimated that 90% of people worldwide will experience 
periodontal disease during their lifetimes [17]. If untreated, periodontitis can lead to bone 
destruction and eventual tooth loss [18]. Periodontitis can be acute or chronic and is not 
associated with a single infecting pathogen [18]. Indeed, periodontal infections are 
polymicrobial diseases and typically associated with disturbances in the indigenous 
microbiota rather than the invasion of a pathogenic species [1, 6, 18]. Since disease 
cannot be attributed to any single organism, the microbial contributions to periodontitis 
have been difficult to study due to the complexity of the system. 
 
In an attempt to better characterize pathogens associated with periodontitis, 
Socransky et al. grouped bacterial species into complexes on the basis of co-occurrence 
(Fig. 1.1) [19]. While these complexes provide generalizations about interactions among 
species, they are not strict rules for infection. The red complex organisms 
(Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia) are most 
commonly associated with adult periodontitis, while disease in adolescents is frequently 
associated with Aggregatibacter actinomycetemcomitans [19]. Of these organisms, 
A. actinomycetemcomitans and P. gingivalis have been extensively studied in mono-
culture, and numerous virulence factors produced by these bacteria have been identified 
4 
 
that likely contribute to disease at infected sites [20, 21]. However, behavior of these 
organisms in polymicrobial communities during infection remains understudied.  
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Figure 1.1 Co-occurring complexes of periodontal bacteria.  
Complexes as defined by Socransky et al. based on co-occurrence of species in 
periodontal plaque [19]. 
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1.3 POLYMICROBIAL SYNERGY 
 
1.3.1 Polymicrobial synergy in periodontitis 
The microbes residing in the subgingival crevice are almost exclusively found in 
that environment and are highly adapted to their lifestyles. As such, they have evolved to 
interact with one another in both healthy and diseased states. These interactions can lead 
to synergy, thereby exacerbating disease [22, 23]. Synergy occurs when two microbes 
together produce disease that is worse than the sum of the disease caused by the two 
organisms in isolation. Synergy between oral microbes is quite common [22-24], but 
often the molecular mechanisms underlying synergy are unknown.  
 
1.3.2 Synergy in model polymicrobial infections 
Recent studies have shown that metabolic interactions and interspecies bacterial 
communication can lead to synergy [22, 25]. Due to the importance of synergy in 
periodontitis, our lab has focused on synergistic interactions between 
A. actinomycetemcomitans and oral streptococci, two model organisms that inhabit the 
subgingival crevice. While we have shown that synergy with Streptococcus gordonii is 
dependent upon hydrogen peroxide sensing and lactate consumption [22], we know little 
about the global genetic regulatory mechanisms mediating these processes. This 
pioneering work has primarily been performed in vitro and in model infections. 
Therefore, the mechanisms underlying synergy in human infections remain 
uncharacterized and largely unexplored. 
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1.3.3 Bacterial gene regulation 
Bacterial gene regulation is extremely complex and undoubtedly plays an 
essential role in synergistic interactions. Preliminary studies have revealed some 
regulators that play roles in model interactions. Work in our lab showed that the OxyR 
transcriptional regulator is used by A. actinomycetemcomitans to sense streptococcus-
derived peroxide and increase resistance to innate immunity [16]. In otitis media, 
intercellular signaling was shown to mediate polymicrobial biofilm formation and 
enhance antibiotic resistance [25]. These studies demonstrate the importance of gene 
regulation in synergistic interactions. Yet for most infections we know very little about 
global genetic regulatory processes that mediate polymicrobial synergy.  
 
Bacteria regulate gene expression in response to numerous stimuli, including 
host- and microbe-derived stresses. Bacteria process information from their environments 
using membrane-bound sensors that detect environmental perturbations, intracellular 
sensor proteins, DNA-binding proteins, and non-coding RNA regulators (discussed 
below). As a result, regulation occurs temporally and hierarchically. Sigma factors, such 
as sigma 70, are regulatory proteins that bind RNA polymerase and recognize consensus 
promoter sequences to drive gene expression under set environmental conditions [26]. 
Transcriptional regulators, like OxyR and Fur, bind DNA directly, controlling 
transcription from specific promoters in response to very specific stimuli [27, 28]. 
Genetic regulation is fine-tuned further by regulatory RNAs [29]. Due to the complex 
nature of these regulatory processes, it is difficult to predict which genes, proteins, and 
RNAs will affect interspecies interactions among bacteria. If we can define genetic 
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regulatory networks involved in polymicrobial diseases, we can then develop therapies to 
disrupt these regulatory schemes. 
 
1.3.4 Bacterial non-coding RNAs 
In addition to sigma factors and transcriptional regulators, bacteria use a myriad 
of non-coding RNAs (ncRNAs) to modulate gene expression. There are several types of 
regulatory bacterial ncRNAs, including small non-coding regulatory RNAs (sRNAs) and 
riboswitches. Bacterial sRNAs are post-transcriptional regulators that hybridize with 
target mRNAs and modulate mRNA stability or translation in trans [29]. Typically, RNA 
chaperone proteins facilitate sRNAs/mRNA hybridization, of which Hfq is the most 
common and widespread [30]. Due to their mechanism of action, bacterial sRNAs have 
been likened to eukaryotic microRNAs and regulate important cellular processes 
including metabolism and virulence. Riboswitches are cis-regulatory mRNA elements 
that act as structured sensory elements [31]. Riboswitches function by binding small 
intracellular molecules, which leads to a conformational change in the mRNA structure, 
impacting either transcription or translation of the mRNA. Riboswitches commonly 
regulate genes involved in amino acid and vitamin metabolism and transport [31]. 
Among oral bacteria, few regulatory ncRNAs have been characterized, especially in 
relation to biofilm formation and metabolism.  
 
Bacteria use another class of ncRNAs, termed clustered regularly interspaced 
short palindromic repeats (CRISPR) RNAs (crRNAs), to defend against parasitic genetic 
elements [32]. These ncRNAs derive their names from the curious repetitive DNA 
elements from which they are transcribed. Found in eubacteria and archaea, CRISPRs 
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consist of anywhere from two up to hundreds of short DNA direct repeats (20-30 bp 
each) separated by similar length variable spacer sequences [33]. Their role in genome 
defense was proposed when researchers discovered that the spacer sequences in the 
CRISPRs were sometimes identical to phage and plasmid DNA sequences [34]. crRNAs 
are transcripts containing a spacer sequence flanked by half of each adjacent repeat. They 
function by hybridizing with foreign nucleic acids, which targets the complex for 
nucleolytic degradation [32]. Surprisingly, CRISPR spacer sequences are identical to 
bacterial chromosomal DNA, which has led researchers to speculate that some bacteria 
may have co-opted CRISPRs for bacterial gene regulation [35]. Similar to the regulatory 
RNAs described above, very little is known about crRNAs in oral bacteria. 
 
1.4 A. ACTINOMYCETEMCOMITANS AS A MODEL ORGANISM 
 
1.4.1 Virulence traits 
Due to its prominence as a potent oral pathogen and synergistic interactions with 
other oral bacteria, our group has studied the biology of the opportunistic oral pathogen 
A. actinomycetemcomitans. A. actinomycetemcomitans is a member of the 
Pasteurellaceae family and a Gram-negative facultative anaerobe. 
A. actinomycetemcomitans can grow on both sugars and lactate, but lactate consumption 
is oxygen-dependent [22]. As mentioned above, it is commonly associated with 
aggressive periodontal infections, particularly in adolescents [19, 20, 36]. Several traits 
likely contribute to A. actinomycetemcomitans success as a pathogen. 
A. actinomycetemcomitans produces both a leukotoxin and cytolethal distending toxin 
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that kill host cells [37-40]. Tight-adherence fimbriae cause A. actinomycetemcomitans 
strains to auto-aggregate, attach firmly to surfaces, and form biofilms [41, 42]. Biofilms 
likely contribute to defense against both phagocytosis and antimicrobial proteins in 
gingival crevicular fluid. Other important self-defense mechanisms of 
A. actinomycetemcomitans include the factor H-binding surface protein, ApiA, and IgA 
protease, which protect it from innate and adaptive host immune systems, respectively 
[16, 43]. Despite these common virulence traits, extensive genomic variation is observed 
among A. actinomycetemcomitans strains [44]. Also, while many people carry 
A.  actinomycetemcomitans, most carry the bacterium asymptomatically [45]. This begs 
the question, what triggers A. actinomycetemcomitans virulence? 
 
1.4.2 Strain diversity 
Diversity among A. actinomycetemcomitans strains abound. Several serotypes 
have been identified based on structural differences in lipopolysaccharide [46]. All 
A. actinomycetemcomitans strains produce a potent leukotoxin that kills eukaryotic cells, 
but certain highly virulent strains produce elevated levels of the leukotoxin due to a 
promoter mutation [47]. A. actinomycetemcomitans is genetically tractable, and some 
strains are naturally competent, or able to take up DNA from the environment and 
undergo natural transformation [48]. Despite these phenotypic differences among strains, 
the genetic bases for these differences were largely uncharacterized until recently. Whole 
genome sequencing and phylogenetic analyses showed that A. actinomycetemcomitans 
strains cluster into clades coordinately with serotype, but some traditional virulence 
factors are not part of the core genome [44]. Interestingly, most strains appeared to 
contain the genes required for natural transformation, suggesting that the common 
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ancestor to A. actinomycetemcomitans could undergo natural transformation, but some 
strains lost this ability throughout evolution. Because natural competence and virulence 
vary among strains, A. actinomycetemcomitans evolution with respect to these processes 
is of particular interest. 
 
1.4.3 Natural transformation and evolution 
A. actinomycetemcomitans natural transformation is relatively well characterized 
since it is closely related to Haemophilus influenzae, a model organism used to study the 
process. However, while nearly all H. influenzae strains are readily naturally 
transformable, or naturally competent, only approximately 25% of 
A. actinomycetemcomitans are competent [48, 49]. The basis for this discrepancy is 
currently unknown, but many competence genes are implicated in natural transformation 
and represent a good starting point for determining the basis of competence and non-
competence for transformation.  
 
Natural transformation requires genes involved in both DNA up-take and 
homologous recombination. Because A. actinomycetemcomitans is Gram-negative, 
extracellular DNA has to cross two membranes before it is incorporated into the 
chromosome via homologous recombination. This process requires genes that encode the 
machinery for a type IV pilus, which binds DNA, and several inner membrane transport 
proteins [50-53]. Additionally, several proteins mediate homologous recombination 
(Figure 1.2) [54, 55]. As in H. influenzae, the transcriptional regulator Sxy coordinately 
regulates competence gene expression [56]. The genes are also subject to catabolite 
repression: in high glucose competence genes are transcriptionally inactive, while in low 
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glucose they are activated [57]. These genes are present in all naturally competent species 
related to A. actinomycetemcomitans, including most of the Pasteurellaceae [58]. 
Therefore, parsimony suggests that natural competence is an ancient trait that has been 
lost throughout the course of A. actinomycetemcomitans evolution. 
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Figure 1.2 Natural transformation of A. actinomycetemcomitans.  
DNA is bound outside the cell possibly through the ComE and ComE1 proteins, crosses 
the outer membrane via a type IV pilus consisting of PilABCD, is transported across the 
inner membrane by Rec2 and ComF, degrading a single strand and leaving single 
stranded DNA in the cytoplasm. The single stranded DNA may be protected by ComM. 
Genes encoding these processes are coordinately regulated by Sxy and Crp [50-57]. 
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Natural selection is clearly acting on competence genes since so many bacteria 
still possess these traits after millennia of evolution. However, this raises the question, is 
competence loss due to drift or selection for competence gene loss? Because competence 
genes allow acquisition of new genetic material they have been theorized to accelerate 
evolution [59]. In addition, alternate theories suggest that competence systems serve to 
acquire nutrients from environmental macromolecules or aid in DNA repair [60]. 
Researchers have attempted to test these theories in the lab, but results have been largely 
inconclusive. Since both competent and non-competent A. actinomycetemcomitans strains 
are commonly isolated, we can use the evolutionary history of this species to address 
these questions. Specifically, we can determine how natural competence loss occurs and 
how this affects A. actinomycetemcomitans evolution. 
 
1.4.3 Model for studying synergy 
A. actinomycetemcomitans is one of many species that naturally populates the 
subgingival crevice. It has evolved to coexist with a diverse set of microbes, and is 
therefore an excellent model organism for studying polymicrobial interactions and 
synergy. In vitro studies have demonstrated that A. actinomycetemcomitans forms mixed 
species biofilms with several oral microbes, including Gram-negative and Gram-positive 
species [61, 62]. Among these, biofilms formed with the Gram-negative bacteria 
Veillonella parvula and Fusobacterium nucleatum demonstrated enhanced development 
over single species biofilms [61]. A. actinomycetemcomitans interacts metabolically with 
streptococci in vitro, preferentially consuming waste produced by oral streptococci, even 
in the presence of higher energy substrates like glucose [14, 22]. These studies 
demonstrate the utility in studying model interactions in vitro, but environmental changes 
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induced by the host during infection also likely influence microbial interspecies 
interactions. Thus, it is essential to build on in vitro methods and examine interactions in 
model infections in vivo. 
 
While primarily associated with periodontitis, A. actinomycetemcomitans has also 
been detected in extra-oral abscesses and endocardial infections [63-65]. Consequently, 
several infection models are relevant for studying A. actinomycetemcomitans in vivo. Our 
lab has used a murine abscess model so study synergistic interactions between A. 
actinomycetemcomitans and S. gordonii [22]. Major advantages to the abscess model 
include the controlled inoculation of defined bacterial species and the ability to remove 
the abscess to assess microbial persistence and disease severity. These studies have 
allowed our group to determine several individual genes from each bacterium that 
mediate synergy [22]. The abscess model also presents a means to discover global genetic 
regulatory mechanisms promoting synergy. One of the goals of this dissertation research 
is to develop tools to perform global transcriptional profiling of abscess infections. These 
data will allow me to define genes impacting A. actinomycetemcomitans fitness in a 
single species abscess infection. Specifically, I will identify genes that are induced in vivo 
and likely contribute to persistence. This dataset will then serve as a baseline for studying 
expression changes in polymicrobial infections. 
 
1.5 DISSERTATION OBJECTIVES 
It is important to define molecular mechanisms promoting polymicrobial synergy 
so that we can target these processes with new therapeutics. I have taken two 
complementary approaches to begin studying mechanisms of synergy in oral bacteria. 
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First, I have studied gene regulation in the model polymicrobial pathogen 
A. actinomycetemcomitans in monoculture biofilms and in single species murine abscess 
infections. The goal of these studies was to better characterize A. actinomycetemcomitans 
gene regulation to serve as a basis for studying A. actinomycetemcomitans gene 
regulation in co-infections with S. gordonii and other microbes. Second, I have examined 
gene regulation in healthy and diseased human periodontal plaque communities to define 
genetic regulatory pathways mediating synergy in vivo. 
 
This dissertation is comprised of 6 chapters. In Chapter 1, I introduced 
periodontal disease, polymicrobial synergy, and the opportunistic pathogen 
A. actinomycetemcomitans. In Chapter 2, I use a bioinformatics prediction to 
experimentally discover the first regulatory RNAs in A. actinomycetemcomitans. This 
study resulted in the characterization of the novel riboswitch-regulated lysine transporter 
LysT. Chapter 3 describes the sequencing of three A. actinomycetemcomitans genomes 
and the evolutionary history of natural competence and CRISPR genetic immunity in 
A. actinomycetemcomitans. In Chapter 4, I use high-throughput RNA sequencing to 
characterize the A. actinomycetemcomitans transcriptome in a murine abscess infection. 
Using these data, I defined fermentative and anaerobic respiratory genes that impact 
A. actinomycetemcomitans fitness in vivo. Chapter 5 builds on the techniques developed 
in Chapter 4 to analyze gene expression of the human oral microbiome in periodontal 
health and disease. I demonstrate that not only do bacteria change in abundance during 
disease, but also differentially regulate gene expression, impacting important disease 
processes. Chapter 6 examines the implications of these studies and proposes potential 
future directions for this research.  
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Chapter 2.  Characterization of a Novel Riboswitch-Regulated Lysine 
Transporter in Aggregatibacter actinomycetemcomitans1 
2.1 INTRODUCTION 
Aggregatibacter actinomycetemcomitans is a Gram-negative opportunistic 
pathogen found exclusively in the mammalian oral cavity and a proposed causative agent 
of localized aggressive periodontitis [36]. Within the oral cavity, 
A. actinomycetemcomitans resides in the gingival crevice, the area around the tooth 
bounded by the tooth surface on one side and the gingival epithelium on the other. The 
gingival crevice is colonized by numerous bacterial species residing in surface-associated 
biofilm communities and is bathed by a serum exudate called gingival crevicular fluid [7, 
66, 67]. Microbes growing in the gingival crevice face an array of host and microbe-
derived stresses including host immune factors such as complement and 
immunoglobulins [66], potentially toxic metabolites such as H2O2 and lactic acid [16, 68], 
intense competition for nutrients, and steep oxygen gradients that may fluctuate 
continuously [7]. While it is clear that A. actinomycetemcomitans senses and responds to 
precise cues in the gingival crevice that allow it to adapt and proliferate in the presence of 
these stresses, little is currently known about the regulatory mechanisms that underlie 
these responses.  
 
Bacteria utilize non-coding regulatory RNAs (ncRNAs) to rapidly respond to 
environmental stresses and alter gene expression [69]. In contrast to transcription factors, 
ncRNAs provide a rapid means of fine-tuning gene expression in response to 
environmental signals [70]. There are two major types of ncRNAs utilized in bacterial 
                                                
1 This Chapter was adapted from the following reference (153, © American Society for Microbiology, 
Journal of Bacteriology, 192: 6240-50). 
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gene regulation. Trans-acting small regulatory RNAs (sRNAs) regulate gene expression 
by binding target mRNAs, which typically reduces target gene mRNA levels due to 
degradation of the mRNA-sRNA duplex or reduces translation of a target gene by 
sequestration of the ribosomal binding site [29]. Cis-acting RNAs, or riboswitches, are 
co-transcribed with the downstream gene(s) they regulate and affect gene expression by 
binding small molecules such as amino acids and nucleotides [31, 71, 72]. Riboswitches 
have two functional components: the aptamer domain that mediates binding to a small 
molecule and the expression platform that controls the downstream gene [31]. Riboswitch 
expression platforms consist of an RNA stem-loop structure that functions in one of two 
ways to control the downstream gene. They can affect translation by occluding the 
ribosomal binding site of the target gene, or they can cause premature transcriptional 
termination of the downstream gene in a rho-independent manner [31].  
 
Based on their importance in numerous other bacteria, we hypothesized that 
ncRNAs would play important roles in A. actinomycetemcomitans response to external 
stresses such as nutrient limitation. A. actinomycetemcomitans provides an excellent 
platform for such studies since it seemingly inhabits a single niche, the mammalian oral 
cavity, where it must respond quickly to changing environmental conditions. Since 
nutrient availability in the gingival crevice is limited due to competition with host cells 
and other microbes, ncRNAs involved in nutrient uptake likely play important roles in A. 
actinomycetemcomitans physiology in vivo. Using a bioinformatic and experimental 
approach, we identified three metabolite sensing riboswitches and nine sRNAs in 
A. actinomycetemcomitans during planktonic and biofilm growth. We also characterized 
the first riboswitch in A. actinomycetemcomitans, a lysine riboswitch, and its target, the 
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novel lysine transport gene, lysT. Finally, we demonstrated that this system is conserved 
in many bacterial species, including the phylogenetically-related pathogen Haemophilus 
influenzae. 
 
2.2 MATERIALS AND METHODS 
 
2.2.1 Bacterial strains and growth conditions 
The bacterial strains used in this study are listed in Table 2.1. Escherichia coli 
was grown aerobically in Luria-Bertani (LB) broth at 37°C, unless otherwise noted. 
A. actinomycetemcomitans was grown at 37°C in Tryptic Soy Broth supplemented with 
0.5% yeast extract (TSBYE) or a chemically defined medium (CDM) containing 20 mM 
glucose [14, 73] in a 5% CO2 atmosphere shaking at 165 RPM. H. influenzae was grown 
in Brain Heart Infusion broth or CDM supplemented with 10 μg/mL hemin and 10 μg/mL 
NAD (sBHI and sCDM, respectively) at 37°C in a 5% CO2 atmosphere shaking at 165 
RPM. Bacterial biofilms were grown either as colony biofilms using 0.4 μm nylon filters 
on top of BHI or TSBYE agar plates [74]. Antibiotic concentrations were: 100 μg/mL 
ampicillin and 20 μg/mL kanamycin for E. coli; 2.5 μg/mL rifampicin for 
A. actinomycetemcomitans; 20 μg/mL kanamycin for H. influenzae. 
 
2.2.2 DNA and plasmid manipulations 
DNA and plasmid isolations were performed using standard methods [75]. 
Restriction endonucleases and DNA modification enzymes were purchased from New 
England Biolabs. Chromosomal DNA was isolated using DNeasy tissue kits (Qiagen), 
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and plasmid isolations were performed using QIAprep spin miniprep kits (Qiagen). DNA 
fragments were purified using QIAquick mini-elute PCR purification kits (Qiagen), and 
PCR was performed using the Expand Long Template PCR system (Roche). DNA 
sequencing was performed by automated sequencing technology using the University of 
Texas Institute for Cell and Molecular Biology sequencing core facility.  
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Table 2.1 Bacterial strains and plasmids used in this study. 
Strain or Plasmid Genotype or morphology Source 
Strains   
A. actinomycetemcomtians VT1169 Smooth strain [76] 
A. actinomycetemcomtians Y4 Smooth strain [77] 
E. coli K12 Wild type [78] 
E. coli DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG φ80dlacZΔM15 
Δ(lacZYA-argF)U169, hsdR17(rK- mK+), (NalR) 
 
E. coli K12 lysP rrnB3 ΔlacZ4787 hsdR514 Δ(araBAD)567 Δ(rhaBAD)568 rph-1, lysP- 
(KmR) 
[79] 
E. coli K12 lysP pPEM-T easy rrnB3 ΔlacZ4787 hsdR514 Δ(araBAD)567 Δ(rhaBAD)568 rph-1, lysP- 
(KmR ApR) 
This study 
E. coli K12 lysP pPJ005 rrnB3 ΔlacZ4787 hsdR514 Δ(araBAD)567 Δ(rhaBAD)568 rph-1, lysP 
(KmR ApR) pPJ005 lysTAa 
This study 
E. coli K12 lysP pPJ018 rrnB3 ΔlacZ4787 hsdR514 Δ(araBAD)567 Δ(rhaBAD)568 rph-1, lysP 
(KmR ApR) pPJ018 lysTH. influenzae 
This study 
H. influenzae 86-028NP Nontypeable [80] 
H. influenzae 86-028NP ΔlysT Nontypeable, lysT (KmR) This study 
Plasmids   
pGEM-T Easy TA cloning vector Promega 
pPJ005 A. actinomycetemcomitans lysT in pGEM-T easy This study 
pPJ018 H. influenzae lysT in pGEM-T easy This study 
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2.2.3 RNA preparation 
Bacterial cultures were mixed 1:1 (vol/vol) with RNAlater (Ambion) and stored 
up to two weeks at 4°C. Total RNA was purified using RNAbee as described by the 
manufacturer (tel-test). RNA samples were treated with DNase to remove contaminating 
chromosomal DNA as described [14].  
 
2.2.4 Northern blot ncRNA screen 
Total RNA was prepared from: exponential phase planktonic A. 
actinomycetemcomitans VT1169; stationary phase planktonic A. actinomycetemcomitans 
VT1169; and A. actinomycetemcomitans VT1169 growing as a colony biofilm [16, 74]. 
Gel load dye II (Ambion) was mixed with 10 μg total RNA and separated on 8% 
polyacrylamide 8 M urea gels. A RNA ladder (Ambion) was transcribed with [α-32P]UTP 
(Perkin Elmer) from the Century Plus Marker Template (Ambion) using the T7 
MaxiScript in vitro transcription kit (Ambion) and served as the size standard. Gels were 
stained with ethidium bromide for imaging using a G:BOX imaging apparatus (Syngene) 
and transferred to nitrocellulose. RNA was UV crosslinked to the nitrocellulose and blots 
were pre-hybridized with ExpressHyb Hybridization Solution (ClonTech) for one hour at 
55°C in a HL-2000 HybriLinker hybridization oven (UVP). DNA oligonucleotide probes 
(Table 2.2) were end-labeled with [γ-32P]ATP (Perkin Elmer) using the Kinase Max 
system (Ambion). Probes were added to the pre-hybridization buffer and incubated 17 
hours at 38°C. Blots were washed in 20 mL 2X SSC 0.1% SDS for 20 minutes at 38°C, 
and the wash was repeated four times. Blots were sealed and exposed to film (Kodak) for 
2-17 hours, and developed with an X-OMAT 2000 Processor (Kodak). 
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Table 2.2 Primers and Northern blot probes used in this study. 
Primer or Probe Sequence (5’-3’) 
Primers  
Aa-lysT-F GTCAGTGGTTCTCCCTTAATATTAG 
Aa-lysT-R GTGCTGGATCACGATTTAACG 
NTHi-lysT-F GGCTTAAGGGTGCTACGGTTGTTCTGGTC 
NTHi-lysT-R GGCTTAAGGGCAAGTTTTTGAATGAGATCACAC 
NTHi1465KO-P1-F CCTTCAACCGCACTTATTGG 
NTHi1465KO-P1-R CAGATAGCCCAGTAGCTGACATGTAGTGATTGGGGAGATTACCG 
NTHi1465KO-P2-F GCGGGACTCTGGGGTTCGAAATGTGTGATCTCATTCAAAAACTTG 
NTHi1465KO-P2-R GAAGTGCGGTCAAATTCCAAAC 
NTHi1465KO-verify GTAATGCGCGATTCGATAAAC 
Kan-F ATGTCAGCTGGGCTATCTG 
Kan-R ATTTCGAACCCCAGAGTCCCGC 
lysRS-PE CTTTTAACTGATTTCGGCAAACG 
Aa-lysT-RT-F GTTATTTGCGTTGTTACTCGCCATC 
Aa-lysRS-lysT-RT-F  GTTGGTGACGTCTTCGAAAGAACCG 
Aa-lysT-RT-R AAGGCGCGCTTACTGCCGGACATAC 
Probes  
Glycine-Probea AAAGTACCTTGGATCTCTCCAAGGG 
FMN-Probea TTTCACCCTGCCCTGAGAATGCG 
aa35-Probea GCAATACTTAACAGATGTGGCTTATG 
aa84-Probea CTTGGACGGGGCTTGAATGAGGTCA 
aa89-Probea TTACCGCCTTATCTTCACAAAGCGC 
aa337-Probea CTCAAGCCTAAATCCTGAATTTGC 
aa575-Probea GGTTGTGCTTTTTTAAGCACTGGG 
aa673-Probea TCCACCTTTCCAGCCTTCCCAATTA 
aa734-Probea CCGCACTTTAGTTTTTAGTTTCCTCCG 
Alpha_RBS-Probea CAGGATACTCAAACAGAGTGTCAAGG 
GcvB-Probea GGAAACTCTTTAACCAGTAAG 
Aa-lysRS-Probea CACCGTTATCCACTCGGAAAATATAC 
Aa-lysRS-Probe-F GGAATTCCTAATACGACTCACTATAGGGAACAGTAGCGCTCCATAGTTG 
Aa-lysRS-Probe-R CCCAAGCTTGGGCAAAAAACGCGTCGGGGTTTAGCCCGACGACTTGTGTAGAGGTGCAAA 
NTHi-lysRS-Probe-F TAATACGACTCACTATAGGGCAACCGTAGCACTCCATAG 
NTHi-lysRS-Probe-R GTAGAGGCGCAATTATTATAAG 
NTHi-lysT-Probe-F TAATACGACTCACTATAGGGTCGGTGCTGCCGTTGAATC 
NTHi-lysT-Probe-R TCGTGCCTTTGCTGAATGG 
aDNA oligonucleotide probe. 
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2.2.5 Primer extension analysis 
Primer extension analysis was performed as previously described [81, 82] using a 
6-carboxyfluorescein (FAM)-labeled primer, lysRS-PE (Table 2.2), to synthesize cDNA 
from 20 μg A. actinomycetemcomitans VT1169 colony biofilm RNA. Prior to primer 
extension, RNA integrity was confirmed by agarose gel electrophoresis. 1 μl of a 0.4 μM 
5'-FAM labeled primer was added to the RNA (20 μl final volume) and incubated for 10 
minutes at 70°C. The mixture was chilled in an ice water bath, incubated 20 minutes at 
65°C, and held at 42°C. cDNA synthesis reagents (8 μl 5X buffer, 4 μl 0.1 M DTT, 4 μl 
10 mM dNTPs, and 4 μl SuperScript II (Invitrogen)) were added to the mixture, and the 
reaction was incubated 2 hours at 42°C before ethanol precipitation. cDNA sizing was 
performed at the University of Oklahoma Health Sciences Center Laboratory for 
Genomics and Bioinformatics. Fragment analysis was conducted using Peak Scanner 
software (Applied Biosciences).  
 
2.2.6 RT-PCR for AA02294, lysT, and the lysine riboswitch 
1 μg RNA from lysine-starved A. actinomycetemcomitans Y4 was treated with 
RQ1 DNase (Promega) and used as a template for random primed cDNA synthesis with 
SuperScript II reverse transcriptase. A negative control reaction lacking reverse 
transcriptase was also performed (-RT). Reverse transcriptase reactions were purified 
with QIAquick spin columns (Qiagen). Three different products were amplified from 10 
ng cDNA template that correspond to different regions of the lysT mRNA. A portion of 
the middle of the coding region of A. actinomycetemcomitans lysT was amplified using 
Aa-lysT-RT-F and Aa-lysT-RT-R (Table 2.2). A region spanning the lysine riboswitch 
and the coding region of lysT was PCR amplified using Aa-lysRS-lysT-RT-F and 
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Aa-lysT-RT-R (Table 2.2). A region corresponding to the 3’ end of the lysT mRNA was 
PCR amplified using Aa-lysT-3’-F and Aa-lysT-3’-R (Table 2.2). A. 
actinomycetemcomitans chromosomal DNA served as a positive control template and the 
-RT products served as a negative control template. PCR products were separated on an 
agarose gel, stained with ethidium bromide, and visualized with a G:BOX imaging 
apparatus. 
 
2.2.7 Agarose gel Northern blots 
A. actinomycetemcomitans, H. influenzae, or H. influenzae ΔlysT were grown 
overnight in TSBYE or sBHI, respectively, pelleted by centrifugation, washed three times 
in CDM or sCDM free of L-lysine, resuspended in the same lysine-free medium and 
starved for L-lysine for two hours. A fraction of the cells was removed from the culture 
for RNA extraction, and 10 mM L-lysine was added to the growth medium. Cells were 
removed from the culture for RNA extraction at 15, 30, 60, and 120 minutes after the 
addition of L-lysine.  
 
Northern Max glyoxal load dye (Ambion) was mixed 1:1 (vol/vol) with 20 μg 
total RNA from each sample and incubated at 50°C for 30 min. RNA was immediately 
separated by gel electrophoresis on a 2% agarose gel using the Northern Max buffer 
system (Ambion). Ethidium bromide stained RNA gels were imaged using a G:BOX 
imaging apparatus. Wells were cut away from gels, and RNA was transferred to 
nitrocellulose by downward transfer for 4 hours using a Whatman Turboblotter. RNA 
was UV crosslinked to the nitrocellulose and blots were pre-hybridized with UltraHyb 
buffer (Ambion) for one hour at 68°C in a HL-2000 HybriLinker hybridization oven. 
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RNA probe templates were PCR amplified from A. actinomycetemcomitans chromosomal 
DNA with primers Aa-lysRS-Probe-F and Aa-lysRS-Probe-R (Table 2.2), or from 
H. influenzae chromosomal DNA using NTHi-lysRS-Probe-F and NTHi-lysRS-Probe-R 
(probe 1, Fig. 2.7A) or NTHi-lysT-Probe-F and NTHi-lysT-Probe-R (probe 2, Fig. 2.7A) 
(Table 2.2). RNA probes were in vitro transcribed from PCR templates with [α-32P]UTP 
(Perkin Elmer) using the T7 MaxiScript system. Probes were added to the pre-
hybridization buffer and incubated 17 hours at 68°C. Blots were washed in 20 mL 2X 
SSC 0.1% SDS for 10 minutes at 25°C and washed twice more in 0.1X SSC 0.1% SDS 
for 15 min each at 68°C. Blots were then sealed and exposed to a phosphor screen 
(BioRad), imaged using a Personal Molecular Imager (BioRad), and processed with 
Quantity One software (BioRad). 
 
2.2.8 Lysine riboswitch half-life 
A. actinomycetemcomitans Y4 was grown overnight in TSBYE, washed three 
times in lysine-free CDM, resuspended in lysine-free CDM, and starved for lysine for 
two hours. After starvation, 10 mM L-lysine was added to the growth medium, and 15 
min later rifampicin was added to the culture to inhibit transcription. At 0, 5, 10, 20, and 
40 min after rifampicin treatment cells were removed for RNA extraction. RNA samples 
were subjected to polyacrylamide urea gel Northern blot analysis (as described above) 
probing for the A. actinomycetemcomitans lysine riboswitch with Aa-lysRS-Probe (Table 
2.2). Northern blots were exposed to a phosphor screen, imaged on a Personal Molecular 
Imager, analyzed by densitometry with Quantity One software. The half-life was 
calculated using the following equation: H=t((ln(0.5))/(ln(Sf/S0))) where H= half-life, t= 
time , Sf= final signal, and S0= original signal.  
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2.2.9 Expression of A. actinomycetemcomitans lysT and H. influenzae lysT in the 
E. coli lysP mutant 
A. actinomycetemcomitans lysT was PCR amplified from 
A. actinomycetemcomitans Y4 chromosomal DNA using the primers Aa-LysT-For and 
Aa-LysT-Rev (Table 2.2). The PCR product was ligated into pGEM-T Easy TA cloning 
vector (Applied Biosystems) to create pPJ005, which was introduced into E. coli DH5α 
and the lysP mutant obtained from the Keio collection [79]. Similarly, lysT was PCR 
amplified from H. influenzae 86-028NP chromosomal DNA with NTHi-LysT-For and 
NTHi-LysT-Rev (Table 2.2). The PCR product was ligated into pGEM-T Easy to 
construct pPJ018, which was introduced into E. coli DH5α, strain K12, and the lysP 
mutant obtained from the Keio collection [79]. Plasmid constructs were confirmed by 
restriction enzyme digest and DNA sequencing. 
 
2.2.10 Constructing a H. influnezae ΔlysT mutant 
Allelic replacement of H. influenzae lysT was performed by natural 
transformation of H. influenzae strain 86-028NP as previously described [83, 84]. The 
regions flanking lysT on the H. influenzae chromosome were PCR amplified with 
NTHi1465KO-P1-F, NTHi1465KO-P1-R, NTHi1465KO-P2-F, and NTHi1465KO-P1-R 
and a kanamycin resistance gene (aphA) was amplified from pBBR1MCS-2 [85] using 
Kan-F and Kan-R (Table 2.2). The kanamycin resistance gene was placed between the 
two flanking regions by overlap extension PCR [86]. The resulting ~4 kb PCR product 
was then gel purified with a QIAquick gel purification spin column (Qiagen), and 2 μg 
product was used to transform H. influenzae 86-028NP by natural transformation [83, 
84]. H. influenzae ΔlysT mutants were selected on sBHI agar + 20 μg/mL kanamycin. 
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Chromosomal DNA was extracted from mutants and allelic replacement was confirmed 
by PCR amplification with NTHi1465KO-verify and KanR primers (Table 2.2). 
 
2.2.11 Lysine transport assays 
Bacteria were grown overnight in either LB or sBHI for E. coli and H. influenzae, 
respectively. Cultures were diluted 1:1 in the same medium and incubated 1 hour shaking 
at 37°C. E. coli was washed three times in lysine-free MOPS 20 mM glucose 5 μg/mL 
Fe2SO4 700 μg/mL MgSO4 100 μg/mL CaCl2 (MOPS) and H. influenzae was washed in 
lysine-free sCDM, and resuspended in 500 μL of the same medium to OD600 0.40. 
Bacteria were incubated for 5 min at 37°C and 4 μCi (100 nM) [14C]L-lysine was added 
and incubated at 37°C. At 10 and 20 min, 250 μL was removed from each transport 
reaction and quenched with 2.5 mL ice cold MOPS or sCDM with 10 mM L-lysine. The 
quenched transport reactions were filtered through a 0.4 μm filter, the filters were washed 
with 3 mL ice cold MOPS or sCDM with 10 mM L-lysine, and the filters were placed in 
4 mL Ecolite scintillation fluid and counted on a Beckman-Coulter LS6500 liquid 
scintillation counter. Endpoint cold competition transport assays were carried out for 20 
minutes, as described above, however the medium used for the transport assay contained 
20 mM of the competing amino acid (i.e. L-arginine, L-glycine, or L-lysine). 
 
2.2.12 Lysine riboswitch RNA secondary structure analyses 
The A. actinomycetemcomitans lysine riboswitch nucleotide sequence was 
analyzed with Mfold to predict the RNA secondary structure [87]. The homologous 
sequence upstream of NTHi1465 was also analyzed with Mfold [72, 87]. Both riboswitch 
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structures were compared to lysine riboswitch crystal structures from Thermotoga 
maritima to identify conserved lysine-binding nucleotides and structural elements [88, 
89]. 
 
2.2.13 Identifying LysT homologs and putative lysine riboswitches 
BLASTp analysis was used to find proteins homologous to 
A. actinomycetemcomitans LysT, with an e-value cutoff of 10-100 [90]. ClustalW (version 
1.83) was used to align amino acid sequences of proteins from 64 species and conduct 
phylogenetic analysis with 1000 bootstrap replicates [91]. Phylogenetic trees were drawn 
with Tree View software [92]. All loci encoding BLASTp LysT homologs were analyzed 
for putative lysine riboswitches in the 400 bp region upstream of their start codons. The 
400 bp region was analyzed with RiboSW software which scanned for any riboswitches 
in the sequence. When a putative lysine riboswitch was identified by RiboSW, the 
predicted riboswitch start location relative to the start codon was recorded, along with the 
free energy associated with the secondary structure, and the corresponding HMM e-value 
[93].  
 
2.2.14 Glycine riboswitch RNA secondary structure analyses 
The intergenic region upstream of AA00167 was analyzed with RiboSW to 
identify the putative glycine riboswitch sequence [93]. Mfold software was used to 
generate a secondary structure, which was then compared to the consensus glycine 
riboswitch structure determined by Kwon and Strobel [72, 87]. 
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2.3 RESULTS 
 
2.3.1 Discovery of A. actinomycetemcomitans regulatory RNAs 
While there has not been an investigation of ncRNAs in A. 
actinomycetemcomitans, a recent in silico analysis predicted 35 ncRNAs encoded in 
intergenic regions of the A. actinomycetemcomitans genome 
(http://www.oralgen.lanl.gov/). To determine if these predicted ncRNAs are produced by 
A. actinomycetemcomitans, RNA was isolated from logarithmic, stationary phase, and 
colony biofilm cells, and Northern blot analysis was used to probe for 23 of the predicted 
ncRNAs. Twelve ncRNAs were detected, including 3 putative riboswitches and 9 sRNAs 
ranging in size from ~110-500 nt (Table 2.3). Of the 12 ncRNAs identified, 8 were 
identified under all growth conditions, and 4 were only observed in colony biofilm-grown 
A. actinomycetemcomitans. Additionally, several ncRNAs (putative glycine riboswitch, 
putative lysine riboswitch, Aa84, Alpha_RBS, Aa337, GcvB, and Aa575) were expressed 
at higher levels during biofilm growth. We chose to further characterize the putative 
lysine riboswitch since it was only observed in colony biofilms, it possessed high 
homology to characterized lysine riboswitches, and it was positioned upstream of a gene 
of unknown function that is conserved in a large number of bacteria (see below).  
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Table 2.3 Riboswitch and sRNA discovery in A. actinomycetemcomitans. 
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2.3.2 Mapping the transcriptional start site and promoter of the putative lysine 
riboswitch 
To determine a transcriptional start site and map a putative promoter region for 
the putative lysine riboswitch, primer extension was used. The major primer extension 
product was 93 nt in length (Fig. 2.1A), corresponding to an adenine transcriptional start 
site (Fig. 2.1B) positioned 7 bp upstream of the predicted riboswitch aptamer domain and 
267 bp upstream of the hypothetical gene AA02294 (Fig. 2.1D). A promoter with a -10 
site and a -35 site was identified upstream of the transcriptional start site (Fig. 2.1B). 
Little is known about A. actinomycetemcomitans promoters, but this promoter varies 
considerably from the canonical E. coli sequence for these sites. Upstream and in the 
opposite orientation of the putative riboswitch is hns, which encodes a global 
transcriptional regulator [94]. A canonical rho-independent terminator was identified 4 bp 
downstream of the aptamer domain (Fig. 2.1C).  
  
33 
 
 
Figure 2.1 Mapping the transcriptional start site of the A. actinomycetemcomitans 
AA02294 lysine riboswitch with primer extension analysis.  
(A) Fluorescent intensities of primer extension products synthesized from 
A. actinomycetemcomitans colony biofilm RNA. Fluorescent peak height corresponds to 
cDNA levels. (B) Transcriptional start site (+1) and promoter sequence for the A. 
actinomycetemcomitans AA02294 lysine riboswitch. The sequence complementary to the 
primer used for primer extension is boxed, the transcriptional start site is bold-faced, and 
the putative -10 and -35 promoter sequences are underlined. Sequence begins at 
1,563,524 and ends at 1,563,723 on the A. actinomycetemcomitans chromosome. (C) The 
AA02294 lysine riboswitch rho-independent terminator. The terminator begins at +168 
and terminates at +202 relative to the transcriptional start site. (D) Schematic of the 
A. actinomycetemcomitans AA02294 lysine riboswitch genomic context. The arrow 
indicates the transcriptional start site determined by primer extension analysis and the 
rho-independent terminator is shown as a hairpin. Image is drawn to scale. 
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2.3.3 Structural predictions demonstrate features characteristic of lysine 
riboswitches 
Structures of riboswitch aptamers are critical for their function. Structural studies 
of lysine riboswitch aptamers show two characteristic elements: an "RNA kissing loop" 
that binds L-lysine at the base of the two loops; and a loop E motif that enables RNA 
twisting [88, 89, 95]. The secondary structure prediction program Mfold was used to 
generate an RNA secondary structure of the putative A. actinomycetemcomitans lysine 
riboswitch based on free energies of internal base-pairing [87] (Fig. 2.2A). The predicted 
structure has the characteristic kissing loops and loop E motif. Conserved nucleotides 
known to be important for coordinating L-lysine at the base of the kissing loops were also 
present [89] (Fig. 2.2A), providing strong in silico support that this ncRNA is a lysine 
riboswitch.  
 
2.3.4 The riboswitch accumulates in the presence of lysine 
Riboswitches are co-transcribed with the genes they regulate [96]. To determine 
whether this putative riboswitch formed a contiguous transcript with the downstream 
gene AA02294, RT-PCR was used. Primers were designed to amplify a region spanning 
the riboswitch and the AA02294 coding region (Fig. 2.2B). Our results reveal that A. 
actinomycetemcomitans does produce a contiguous mRNA containing both the putative 
riboswitch and AA02294. Based on the location of this mRNA, we hypothesize that the 
putative riboswitch serves as a cis-regulatory element in the 5' untranslated region of 
AA02294. 
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Figure 2.2 The A. actinomycetemcomitans AA02294 lysine riboswitch.  
(A) Predicted structure of the A. actinomycetemcomitans lysine riboswitch aptamer. The 
structure was predicted using Mfold software [87]. Structural motifs conserved in all 
lysine riboswitches, kissing loops and loop E motif, are identified. Boxed nucleotides are 
predicted to be involved in binding lysine based on sequence and structural homology to 
the crystal structure of the lysine riboswitch from T. maritima [88, 89]. (B) RT-PCR 
detecting the AA02294 mRNA (Products 1 and 3) and the read through transcript 
containing both the lysine riboswitch and AA02294 (Product 2). The positive control 
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reactions (gDNA) show PCR amplification from A. actinomycetemcomitans 
chromosomal DNA, while the negative control (-RT) represents PCR amplification from 
cDNA synthesis reactions without reverse transcriptase added, and the final lane (cDNA) 
depicts PCR amplification from cDNA synthesized from RNA harvested lysine-starved 
A. actinomycetemcomitans. (C) The AA02294 lysine riboswitch accumulates in the 
presence of lysine. A. actinomycetemcomitans lysine-starved cells (- lys, 0 min) were 
exposed to lysine (+ lys) and samples removed at 15, 30, 60 and 120 min post-addition. 
The arrow indicates where the full-length lysT transcript should be detected. RNA from 
each timepoint was subjected to Northern blot analysis using a probe for the lysine 
riboswitch.  
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Upon binding lysine, most lysine riboswitch expression platforms prematurely 
terminate transcription of the downstream gene [71, 89, 95-98]. Because we identified a 
potential rho-independent terminator downstream of the lysine aptamer domain and 
upstream of AA02294 (Fig. 2.1C), we hypothesized that A. actinomycetemcomitans 
grown in the presence of lysine would produce high levels of the prematurely terminated 
riboswitch transcript compared to lysine-starved cells. To test this hypothesis, Northern 
blot analysis was carried out to probe for the riboswitch in the absence and presence of 
lysine. As anticipated, the terminated riboswitch transcript is only present after the 
addition of lysine to the media (Fig. 2.2C), consistent with previous studies of lysine 
riboswitches [71, 96]. The full-length mRNA (approximately 2000 nt) was not observed 
by Northern blot, although in the absence of lysine, an RNA larger than the riboswitch 
was detected (0 min, Fig. 2.2C). Thus, it appears that the full length transcript is unstable 
or there is a technical issue in detecting the riboswitch when present in the full length 
transcript. Importantly, the full length transcript could be detected by RT-PCR (Fig. 
2.2B), and the full-length transcript along with the riboswitch were detected in the closely 
related bacterium H. influenzae (see below).  
  
2.3.5 Riboswitch half-life 
Since the prematurely terminated transcript accumulated to high levels upon 
exposure to lysine (Fig. 2.2C), we used Northern blot analysis to calculate the lysine 
riboswitch half-life. For these experiments, A. actinomycetemcomitans grown in the 
absence of lysine were exposed to lysine to induce production of the riboswitch. After 15 
min, the transcription inhibitor rifamipicin was added and degradation of the riboswitch 
over time was monitored using Northern blots and densitometry (Fig. 2.3). The results 
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indicate that the riboswitch has a half-life of 17 ± 4 min, which is nearly five times the 
average half-life of an E. coli transcript (3.69 min) [99]. 
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Figure 2.3 The A. actinomycetemcomitans lysine riboswitch has a half-life of 
17 ± 4 min. 
A. actinomycetemcomitans lysine-starved cells were exposed to lysine and treated with 
rifampicin (Rif) to stop transcription. Lysine riboswitch levels were monitored by 
Northern blot analysis and half-life was calculated as described in Materials and 
Methods. The ethidium bromide stained gel was used to ensure equal RNA loading. 
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2.3.6 A. actinomycetemcomitans lysT encodes a novel lysine transporter 
Lysine riboswitches have been shown to regulate lysine biosynthetic genes in B. 
subtilis and the lysine transport gene lysP in E. coli [71, 100]. The gene downstream of 
the A. actinomycetemcomitans lysine riboswitch, AA02294, is a hypothetical gene of 
unknown function. A previous study hypothesized that genes downstream of several 
lysine riboswitches encoded novel lysine transporters, although no empirical evidence 
was provided to test this hypothesis [100]. There are several well characterized bacterial 
lysine transporters, including the lysine-specific LysP transporter in E. coli [101, 102], 
the lysine-arginine-ornithine (LAO) transporter in E. coli [103], and LysI in 
Corynebacterium glutamicum [104]. While LysI and LysP uniquely transport lysine, the 
LAO transporter preferentially transports arginine and ornithine [105]. Despite the 
prevalence of several bacterial lysine transporters, no lysine transport genes are annotated 
in the A. actinomycetemcomitans genome. Bioinformatic analysis with Phyre protein 
prediction software predicted that AA02294 encodes an inner membrane transport protein 
[106] with an NhaC domain [107-109]. Despite having no homology to other lysine 
transporters, these observations led us to hypothesize that AA02294 encodes a novel 
lysine transporter. 
 
To determine whether A. actinomycetemcomitans AA02294 encodes a lysine 
transporter, we tested its ability to heterologously restore lysine transport in an E. coli 
lysine transport mutant. A plasmid carrying A. actinomycetemcomitans AA02294 
(pPJ005) was transformed into an E. coli lysP mutant that is unable to take up L-lysine, 
and the ability of this strain to transport [14C]L-lysine was assessed. Expression of 
AA02294 in trans restored L-lysine transport to the E. coli lysP mutant (Fig. 2.4A), 
41 
 
indicating that AA02294 encodes a novel lysine transporter (referred to as LysT). It was 
also important to determine the specificity of LysT since some lysine transporters have 
been shown to also transport L-arginine [102, 105]. To test the specificity of lysT, the 
ability of unlabeled L-lysine, L-arginine, and L-glycine to inhibit uptake of [14C]L-lysine 
by the E. coli lysP mutant expressing A. actinomycetemcomitans lysT was assessed. The 
addition of unlabeled L-lysine reduced uptake of [14C]L-lysine to background levels 
while addition of unlabeled L-arginine inhibited [14C]L-lysine uptake approximately 50% 
(Fig. 2.4B). The addition of unlabeled glycine had no effect on lysine uptake.  
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Figure 2.4 A. actinomycetemcomitans lysT restores lysine transport in an E. coli 
lysine transport mutant.  
(A) Transport of [14C]L-lysine by the E. coli lysP mutant with an empty vector (-, black) 
or a vector expressing A. actinomycetemcomitans lysT from pPJ005 (lysT, white). 
Transport was measured in counts per minute at 10 and 20 minutes after the addition of 
[14C]L-lysine to the assay. (B) Unlabeled L-lysine inhibits up-take of [14C]L-lysine by A. 
actinomycetemcomitans LysT. Lysine transport assays were carried out in the presence of 
excess unlabeled glycine, L-arginine, or L-lysine. The "-" represents a negative control 
assay where no competing amino acid was added. The data in both graphs represents the 
mean of three independent experiments, error bars in all assays represent the standard 
error, and statistical significance was determined by an unpaired two-tailed Student's t-
test: *P < 0.05, **P < 0.005. 
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2.3.7 Haemophilus influenzae LysT is a lysine transporter 
Although LysT lacks homology to known lysine transporters such as LysP in E. 
coli [101, 102], a BLASTp homology search revealed LysT homologs from 64 species of 
bacteria, including Gamma-proteobacteria, Beta-proteobacteria, and Bacilli (e-value < 
10-100, Fig. 2.5) [90, 110]. Of the genes encoding the LysT homologs, 48 are predicted to 
have lysine riboswitches within 400 bp of their start codons [93]. Included within this 
group containing riboswitches is the LysT homolog (ORF NTHi1465) from the human 
pathogen Haemophilus influenzae which causes otitis media, bacterial meningitis, and 
pulmonary infections [111]. The H. influenzae LysT is a hypothetical inner membrane 
protein with 75% identity and 92% similarity to A. actinomycetemcomitans LysT over 
249 amino acids in the predicted loop regions. To determine if H. influenzae NTHi1465 
encoded a lysine transporter, NTHi1465 was expressed in the E. coli lysP mutant from 
pPJ108 and tested for its ability to restore lysine transport. As expected, heterologous 
expression of NTHi1465 restored the ability of the E. coli lysP mutant to transport lysine 
(Fig. 2.6A), indicating that H. influenzae NTHi1465 encodes a L-lysine transporter. In 
addition, NTHi1465 appears to be the only lysine transporter in H. influenzae as deletion 
of lysT eliminated the ability of H. influenzae to transport lysine (Fig. 2.6B).  
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Figure 2.5 LysT phylogenetic tree.  
(A) LysT homologs were identified by BLASTP analysis (e value cutoff < 10-100), 
aligned, subjected to bootstrap analysis from a plurality of 1000 trees with ClustalW 
(version 1.83) [91]. The phylogenetic tree was drawn with Tree View software [92]. The 
bootstrap values are shown at branch points and the scale bar indicates the distance for 1 
amino acid change in 10 residues. Species with predicted lysine riboswitches in the 
region 400 bp upstream of lysT are noted in red text. (B) Two-fold enlargement of the 
Neisseria sp. clade, (C) the Vibrio sp. clade, (D) the Shewanella sp. clade.  
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Figure 2.6 The H. influenzae lysT homolog NTHi1465 encodes a L-lysine 
transporter. 
(A) H. influenzae lysT restores lysine transport in an E. coli lysine transport mutant. 
Transport of [14C]L-lysine by the E. coli lysP mutant with an empty vector (-, black) or a 
vector expressing H. influenzae lysT from pPJ018, (lysT, white) was measured in counts 
per minute at 10 and 20 minutes. (B) NTHi1465 encodes the only lysine transporter in H. 
influenzae. Transport of [14C]L-lysine by wild type H. influenzae (wt, black) and the H. 
influenzae ΔlysT (ΔlysT, white) mutant was measured in counts per minute at 10 and 20 
min after the addition of [14C]L-lysine to the assay. “ND” indicates that no lysine uptake 
was detectable. The data are the mean of three independent experiments, error bars in all 
assays represent the standard error, and statistical significance was determined by an 
unpaired two-tailed Student's t-test: *P < 0.05 and **P < 0.005. 
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2.3.8 H. influenzae lysine riboswitch 
As previously discussed, bioinformatics also predicted a putative lysine 
riboswitch upstream and contiguous with H. influenzae lysT. Similar to 
A. actinomycetemcomitans, hns was located upstream of lysT and in the opposite 
orientation (Fig. 2.7A). Structural predictions of the H. influenzae lysine riboswitch 
aptamer domain using Mfold revealed conserved structural elements, as well as complete 
conservation of the nucleotides required for lysine binding (Fig. 2.7B) [87]. Although 
predicted to be structurally similar and contiguous with their respective lysT genes, the 
A. actinomycetemcomitans and H. influenzae riboswitches are localized to different 
positions in regards to the lysT start codons. In A. actinomycetemcomitans, the riboswitch 
is predicted to terminate approximately 50 bp upstream of the start codon for lysT; 
however, in H. influenzae the riboswitch is predicted to overlap the start codon of lysT.  
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Figure 2.7 Lysine riboswitch and lysT homolog in H. influenzae.  
(A) Genomic context of the H. influenzae lysT homolog (NTHi1465) and its lysine 
riboswitch. RNA probes for Northern blot analysis are depicted as arrows 1 and 2. 
(B) Predicted secondary structure of the H. influenzae lysine riboswitch aptamer. Mfold 
was used to predict RNA structure [87]. Structural motifs are noted and predicted lysine-
binding nucleotides are boxed. 
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To determine if the H. influenzae riboswitch acts at the transcriptional level, 
H. influenzae were grown with and without L-lysine, and Northern blot analysis was used 
to probe for both the riboswitch and lysT. Similar to A. actinomycetemcomitans, two 
transcripts were present when using the riboswitch-specific probe: a small transcript 
corresponding to the lysine riboswitch and a larger transcript likely corresponding to the 
degraded riboswitch-lysT transcript (Fig. 2.8A). As expected, the lysine riboswitch 
accumulated upon addition of L-lysine, while the larger transcript disappeared. Since we 
were not able to definitively detect the full length transcript with the riboswitch probe, we 
also utilized a probe specific for lysT. This probe detected a specific mRNA at ~2000 nt, 
corresponding to the full-length lysT mRNA. Also, the probe only hybridized to the full-
length lysT transcript in the lysine-starved samples, and did not detect any transcripts in 
cells exposed to lysine. However, as expected from Northern blots with riboswitch-
specific probes (Fig. 2.2C and Fig. 2.8A), it appears that the full length transcript is 
highly unstable as a number of smaller transcripts were also detected (Fig. 2.8B). 
Importantly, no hybridization was observed when RNA from the H. influenzae lysT 
deletion strain was used (Fig. 2.8A&B), indicating that the transcripts identified in the 
wild-type RNA samples are specific for the riboswitch and lysT. Together these results 
demonstrate that the lysine riboswitch is conserved in H. influenzae and regulates lysT at 
the transcriptional level. 
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Figure 2.8 The lysine riboswitch is conserved in H. influenzae.  
(A) The NTHi1465 lysine riboswitch accumulates in the presence of lysine. H. influenzae 
wild-type and ΔlysT lysine-starved cells (- lys, 0 min) were exposed to lysine (+ lys) and 
samples removed at 15, 30, and 60 min post-addition. RNA from each timepoint was 
subjected to Northern blot analysis using a probe for the NTHi1465 L-lysine riboswitch. 
(B) H. influenzae lysT diminishes upon addition of lysine. The RNA samples from the 
lysine starvation experiment describe above were subjected to Northern blot analysis and 
probed for lysT. Arrows indicate the full-length lysT transcript in both panels. 
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2.4 DISCUSSION 
The study describes identification of 12 new ncRNAs in 
A. actinomycetemcomitans. While most of these ncRNAs were produced by planktonic 
and biofilm bacteria, several appear to be produced at higher levels in biofilm grown 
bacteria. Interestingly, three ncRNAs that are induced in biofilm bacteria have predicted 
functional overlap, specifically they appear to regulate amino acid transport. Along with 
the lysine riboswitch characterized in this study, a putative glycine riboswitch was 
identified upstream of AA00167 (Table 2.3, Fig. 2.9). The riboswitch has structural and 
sequence homology to other glycine riboswitches [72], and AA00167 belongs to the 
sodium/alanine symporter superfamily [112] which includes a known glycine transporter 
[113]. We also observed high levels of an sRNA homologous to GcvB in 
A. actinomycetemcomitans biofilms. In Salmonella enterica serovar Typhimurium and 
E. coli, GcvB regulates more than 10 genes involved in amino acid transport [114-117]. 
Since all three of these ncRNAs are proposed to down-regulate amino acid transport in 
the presence of high levels of intracellular amino acids, these data suggest that within the 
colony biofilm, A. actinomycetemcomitans possesses high intracellular amino acid 
concentrations. In the gingival crevice, A. actinomycetemcomitans and other bacteria are 
known to release proteases that would increase free amino acid pools in the surrounding 
environment [118, 119]. However, free amino acid levels have not been directly 
measured in gingival crevicular fluid. Further studies will be needed to determine if these 
ncRNAs are important for biofilm formation and biofilm-specific phenotypes.   
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Figure 2.9 Glycine riboswitch structural prediction. 
The RNA secondary structure prediction for the A. actinomycetemcomitans glycine 
riboswitch aptamer determined by RiboSW and Mfold analyses [87, 93]. Nucleotides 
conserved in 75% (black boxes), 90% (blue boxes), and 97% (red boxes) of identified 
glycine riboswitches are indicated on the structure [72]. 
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While it is not surprising that a lysine riboswitch controls transcription of a gene 
encoding a lysine transporter, the characterization of LysT describes a new family of 
lysine transporters. LysT homologs were identified in 64 species of bacteria, including 
Gram-negative and Gram-positive species (Fig. 2.5), and our studies of H. influenzae 
LysT suggest (Fig. 2.6) that many of the LysT homologs will be involved in lysine 
transport. Interestingly, as in A. actinomycetemcomitans and H. influenzae, riboswitches 
are predicted to regulate transcription of 75% of the LysT homologs. This latter 
observation suggests that riboswitch regulation is a common mechanism for regulating 
transcription of lysine transporters in bacteria. This mode of regulation allows 
transcription to be linked to intracellular lysine concentrations; thus allowing bacteria to 
fine-tune expression in real-time in response to changing lysine levels.  
 
While not examined in this study, lysine riboswitches could also play important 
regulatory roles aside from regulating genes involved in lysine transport and biosynthesis. 
Because our Northern blot analyses showed that the lysine riboswitch has a relatively 
long half-life of approximately 17 min (Fig. 2.3), the lysine riboswitch could act as a 
trans-regulatory sRNA in a lysine-dependent signaling process. Interestingly, Phan and 
Schumann noted a similar result in Bacillus subtilis [96], and also postulated that the 
prematurely terminated lysine riboswitch might serve additional functions within the cell. 
This is not unreasonable as the S-adenosyl methionine riboswitch in Listeria 
monocytogenes is known to regulate an important virulence regulator in trans [120].  
 
This study used bioinformatic and experimental approaches to identify ncRNAs in 
A. actinomycetemcomitans, some of which appear to be highly expressed in biofilms and 
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others which have no known homologs (Aa35, Aa84, Aa337, and Aa575). These results 
provide the first insight into ncRNAs in A. actinomycetemcomitans, providing a basis for 
future functional studies. There is no doubt that more ncRNAs are produced by A. 
actinomycetemcomitans, many of which may be specific for other growth environments 
such as the oral cavity or in polymicrobial communities. Future studies will address the 
overall expression of ncRNAs in A. actinomycetemcomitans and determine specific 
regulatory functions that ncRNAs serve, not only within a single bacterium, but within 
complex polymicrobial communities. 
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Chapter 3. An Evolutionary Link between Natural Transformation and 
CRISPR Adaptive Immunity2 
3.1 INTRODUCTION 
Natural transformation is a primary means of bacterial horizontal gene transfer 
(HGT). Natural transformation occurs when environmental cues trigger the expression of 
competence genes, which allow the bacterium to take up DNA from its environment and 
incorporate new genes into its genome. Bacterial competence systems can vary among 
species, but all systems involve DNA transport proteins and machinery that incorporates 
the new DNA into the chromosome via homologous recombination [50-57]. Due to their 
genetic complexities, competence systems are thought to be ancestral traits in many 
bacterial lineages; however, competence loss within bacterial families is common [49, 
121]. Evolutionary models predict that HGT and homologous recombination by natural 
transformation can accelerate adaptation to new environments and allow organisms to 
more rapidly reach fitness equilibria [59, 122]. Despite predictions that competence is a 
beneficial trait, many bacteria are non-competent and, among competent bacteria, 
competence genes are sometimes lost by strains within a species [48, 49]. This leads to 
the hypothesis that throughout evolution naturally competent bacterial populations are 
constantly giving rise to non-competent siblings, and at certain points, non-competent 
genomes are selected for over the dynamic genomes of competent bacteria. 
 
To test this hypothesis, we focused on the evolutionary history of the 
opportunistic human periodontal pathogen Aggregatibacter actinomycetemcomitans, in 
which ~30% of isolated strains are naturally competent [48]. A. actinomycetemcomitans 
                                                
2This Chapter was adapted from the following reference (185, © American Society for Microbiology, 
mBio, 3: e00309-12). 
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is a member of the Pasteurellaceae, a family of bacteria predicted to have descended 
from a competent ancestor [121]. An experimental survey testing natural transformation 
demonstrated that A. actinomycetemcomitans competence loss is clonal [48], suggesting 
that non-competent strains arose and radiated into non-competent lineages. The 
persistence of non-competent A. actinomycetemcomitans strains during evolution allows 
us to utilize genome sequence information to delineate the evolutionary history of 
competence loss and genome stability. Using comparative genomics we identify that 
competence loss has occurred multiple times during A. actinomycetemcomitans evolution 
in parallel. Compared to competent strains, non-competent A. actinomycetemcomitans 
have smaller genomes with fewer rearrangements, as demonstrated by whole genome 
alignments. Pairwise strain average nucleotide identity (ANI) calculations reveal that 
competence loss is tied to evolutionary divergence among A. actinomycetemcomitans 
strains. Moreover, the loss of competence is directly correlated with the loss of A. 
actinomycetemcomitans CRISPR-cas adaptive immune systems, resulting in non-
competent strains with more parasitic genetic elements than competent siblings. In non-
competent strains, remnants of CRISPR-cas systems that remain appear to have been co-
opted for A. actinomycetemcomitans self-gene regulation, similar to eukaryotic 
microRNAs. Together these results support a model for A. actinomycetemcomitans 
evolution whereby competence and non-competence are means to genetic diversity and 
stability, respectively. 
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3.2 RESULTS AND DISCUSSION 
 
3.2.1 Parallel loss of competence by common mechanisms 
Because the Pasteurellaceae common ancestor is predicted to be competent, we 
sought to determine the genetic nature of competence loss throughout 
A. actinomycetemcomitans evolution. Therefore it was important to generate an accurate 
evolutionary history for the species and map competence loss to this phylogeny. The 
alignment of concatenated core genes can be used to accurately determine phylogenetic 
relationships among bacteria [123]. Core genes were aligned from 17 sequenced 
A. actinomycetemcomitans genomes, including 14 previously sequenced strains [44, 124-
126] and 3 genomes sequenced in this study (Table 3.1). The concatenated core gene 
super alignment was subjected to maximum likelihood phylogenetic analysis to 
determine evolutionary relationships between strains, revealing the presence of three 
major A. actinomycetemcomitans lineages (Fig. 3.1). Among these 17 strains, 7 have 
previously been subjected to natural transformation assays and 2 were found to be 
competent [48, 127]. Subsequent alignment of multiple individual competence genes 
from the 17 sequenced A. actinomycetemcomitans genomes reveals that this bacterial 
lineage derived from a competent ancestor, and throughout evolutionary history several 
non-competent lineages have arisen via inactivation or deletion of genes critical for DNA 
uptake and incorporation on the chromosome (Fig. 3.1). The results indicate the presence 
of 3 competent and 14 non-competent sequenced strains, which reflects the prevalence of 
non-competent strains in larger A. actinomycetemcomitans populations [48]. Importantly, 
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the bioinformatics predictions for competent and non-competent strains correlate 
perfectly with results of previously published natural transformation assays. Overall, non-
competence has arisen on at least six independent occasions (Fig. 3.1) with the most 
common mutation (3 occasions) occurring via a site-specific mobile DNA element 
inserting into comM, whose gene product is important for efficient incorporation of DNA 
onto the chromosome following uptake [55]. This pattern of A. actinomycetemcomitans 
competence loss contrasts to other naturally competent bacteria like Haemophilus 
influenzae, in which competence loss is common but occurs randomly throughout 
evolution and typically by many unique mechanisms [49, 58]. Because 
A. actinomycetemcomitans competence loss occurred multiple times during evolution in 
more than one lineage, these data support a model for the parallel evolution of 
competence loss. While parallel evolution is indicative of natural selection, this does not 
mean that competence loss is adaptive; in fact it may be neutral, but the genome content 
of the stably maintained non-competent strains is presumably beneficial. 
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Table 3.1 A. actinomycetemcomitans genome sequencing statistics for de novo 
genome assembly and read-mapping to complete reference genomes. 
de novo Aa 624 Aa VT1169 Aa Y4 
454 reads (bp) 81,529,600 10,992,296 33,150,533 
454 mate-paired reads 257,891 16,220 63,629 
454 coverage 35.8X 5.1X 15.5X 
454 contigs 121 1,250 145 
454 N50 contig size 68,926 1,514 40,197 
454 scaffolds 19 80 8 
454 N50 scaffold size 330,558 32,073 527,427 
454 scaffold total bp 2,279,748 1,873,150 2,142,003 
SOLiD reads (bp) 438,962,055 320,303,340 499,721,075 
SOLiD coverage 191X 147X 233X 
    
read mapping    
best reference D7S-1 HK1651 HK1651 
% coverage 99 97 97 
fold-coverage 25.6X 21.9X 30.4X 
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Figure 3.1 Competence loss occurs throughout A. actinomycetemcomitans evolution. 
The evolutionary history of 17 A. actinomycetemcomitans strains was determined from 
the alignment of 30 concatenated core genes by the Maximum Likelihood method based 
on the Tamura-Nei model with 100 bootstrap replicates, using A. aphrophilus ATCC3392 
and NJ8700 as the out group (Out) [128-131]. Competence is traced with green branches. 
Red branches represent ancestral non-competent lineages while blue branches are recent 
non-competent strains. Roman numerals indicate non-competence branch points. 
Bootstrap values are above the branches and branches reproduced in less than 70% of 
bootstrap replicates are collapsed.  
 
 
  
61 
 
3.2.2 Divergence and speciation of non-competent strains 
Competence is a primary mechanism of HGT and DNA acquisition in bacteria 
[132] and as expected, the genomes of competent A. actinomycetemcomitans strains are 
on average 200,000 bp larger than non-competent strains (2.3 Mb vs. 2.1 Mb, 
respectively; P = 9 x 10-5, two-tailed unpaired t-test). A major consequence of 
competence loss is the inability to acquire new traits via genomic exchange with related 
species, leading to the hypothesis that competence loss leads to genetic isolation, which 
could ultimately result in speciation. To test this hypothesis, we analyzed non-competent 
and competent genomes for genomic rearrangements and average nucleotide identity 
(ANI) across whole genomes. Our results revealed that non-competent strains have 
similar syntenic genomes (i.e. similar gene arrangement), while the competent strains 
have dynamic genomes with multiple rearrangements (Fig. 3.2). Further differences were 
revealed by ANI. Based on a proposed modern species definition (ANI > 95%) [133] the 
non-competent strain with the most ancient branch point (lineage 1, Fig. 3.1) is a 
different species than strains within lineage 2 and lineage 3 (Fig. 3.3). Interestingly, ANI 
comparisons of strains within lineage 2 and within lineage 3 show that strains within 
these lineages are ~99% identical; however comparisons of strains between lineages 2 
and 3 reveal that they differ significantly (ANI ~97%, P < 0.001). Thus lineage 2 and 3 
strains have clearly begun to diverge into distinct populations. This supports a model in 
which competence loss leads to genetic isolation and ultimately divergence in 
A. actinomycetemcomitans. 
  
62 
 
 
 
 
 
 
 
Figure 3.2 Non-competent strains have highly syntenic genomes and competent 
genomes have multiple rearrangements. 
Whole genome alignments of two competent strains (A), a competent and non-competent 
strain (B), and two non-competent strains (C). Blocks represent collinear genomic 
segments and lines indicate rearrangements.  
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Figure 3.3 Speciation of non-competent A. actinomycetemcomitans. 
Pairwise whole genome average nucleotide identities (ANI) within 
A. actinomycetemcomitans lineages (lineage 3 vs lineage 3, n = 21; lineage 2 vs lineage 
2, n = 36), between A. actinomycetemcomitans lineages (lineage 2 vs lineage 3, n = 63; 
lineage 1 vs lineages 2 & 3, n = 16), and between A. actinomycetemcomitans and 
Aggregatibacter aphrophilus (Aa vs A. aphrophilus, n = 17). Each point represents a 
pairwise genome comparison. Bars indicate the mean, and error bars are standard error of 
the mean. ANI between lineages are significantly different (ANOVA test, P < 0.001), 
while within lineage comparisons are not. 
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3.2.3 Non-competent strain diversity due to mobile genetic elements 
Despite the fact that non-competent genomes had high synteny and ANI, some 
differences among non-competent genomes were observed. We hypothesized that non-
competent strains of A. actinomycetemcomitans, having eliminated a predominant 
pathway for HGT, would utilize alternative mechanisms for HGT to maintain 
evolutionary fitness. Indeed, mathematical modeling suggests that in the absence of HGT 
and homologous recombination, genetic drift resulting from the accumulation of random 
neutral mutations will ultimately lead to decreased fitness [59], indicating that at least 
some nominal level of HGT is required for a strain to remain fit. Transducing phage and 
conjugative plasmids are also sources of HGT, and on average there were ~5 unique 
plasmid and phage related DNA elements in each non-competent genome, significantly 
more than that observed in competent lineages which had ~2 (two-tailed unpaired t-test, 
P = 0.02). The unique DNA elements in the non-competent strains include 2 self-
replicating plasmids, 14 integrated plasmid elements, and 22 prophage elements. Thus, 
while non-competent strains possess increased synteny and smaller genomes compared to 
competent strains (Fig. 3.2), the observed differences in DNA content in these strains are 
almost entirely due to incorporation of plasmid and prophage DNA. 
 
3.2.4 Non-competent strains have compromised CRISPR adaptive immune systems 
The presence of plasmids and prophage in the non-competent strains suggest that 
their defenses against foreign nucleic acids were potentially compromised. Bacterial 
adaptive immune systems called clustered regularly interspaced short palindromic repeats 
(CRISPRs) have evolved to protect against phage and plasmid-mediated HGT [32, 134, 
135]. Many variations of CRISPRs exist, and they have been extensively reviewed [136, 
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137]. Briefly, CRISPRs are genetic loci consisting of direct repeats and spacers [33]. 
Spacers are often derived from phage and plasmid DNA [34]. During an infection, short 
CRISPR RNAs (crRNAs) are transcribed from the CRISPR loci and base pair with 
foreign (plasmid and bacteriophage) DNA via spacer encoded sequences [134]. Both the 
invading DNA and crRNA are cleaved by proteins encoded by CRISPR-associated cas 
genes, thereby eliminating the phage and plasmid DNA [32, 135, 138, 139]. Recent work 
has shown that bacteria readily lose CRISPRs under certain selective conditions. 
Specifically, enterococci lost CRISPRs allowing the acquisition of parasite-encoded 
antibiotic resistance genes and Mycoplasma gallisepticum lost CRISPRs following the 
shift to a new avian host [140, 141]. Because CRISPR loss is common in other 
organisms, we predicted that non-competent A. actinomycetemcomitans were more 
susceptible to phage and plasmids due to compromised CRISPR-mediated immunity. To 
test this prediction, we examined the CRISPR-cas content of competent and non-
competent A. actinomycetemcomitans. Based on phylogeny, the common ancestor for 
A. actinomycetemcomitans possessed two CRISPR-cas systems, CRISPR1-cas and 
CRISPR3-cas duplicated from a single system in a more ancient ancestor (Fig. 3.4). 
Indeed, Aggregatibacter aphrophilus has only one CRISPR-cas system related to 
A. actinomycetemcomitans CRISPR1-cas and CRISPR3-cas, supporting the hypothesis 
that they were duplicated from an ancient system. The competent 
A. actinomycetemcomitans strains in our study contain both of these ancient CRISPR-cas 
systems and have acquired a third intact CRISPR-cas system (Fig. 3.4). In contrast, the 
CRISPR-cas systems in ancient non-competent lineage 1 and 2 strains have lost cas 
genes to deletion and/or acquired nonsense mutations in cas genes (Fig. 3.5A). Based on 
these mutations CRISPR elements in non-competent lineage 1 and 2 strains are predicted 
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to be non-functional defensively. CRISPR-cas loss was evident even in the most recently 
evolved (lineage 3) non-competent strains, indicating that loss of CRISPR-cas occurs 
quickly within evolutionary time. The most parsimonious evolutionary history is that 
competence loss preceded CRISPR-cas loss among A. actinomycetemcomitans strains. 
This inference can be drawn because lineage 2 strains share the same disruption of the 
comM competence gene; however, they have many different CRISPR-cas mutations and 
deletions. These data indicate that the emergence of non-competence in 
A. actinomycetemcomitans is correlated with the loss of CRISPR based adaptive 
immunity.  
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Figure 3.4 The representative A. actinomycetemcomitans CRISPR-cas systems in 
D7S-1.  
(A) Representations include the cas genes (arrows) and CRISPRs (black diamonds = 
direct repeats, grey rectangles = spacers). CRISPR-cas locus names and types are 
indicated above each map. Approximate genomic coordinates of CRISPR-cas loci are 
indicated at right and left of each map. Direct repeat sequences are indicated above 
respective maps. Numbers within arrows represent the A. actinomycetemcomitans D7S-1 
ORF number (e.g. “0188” represents D7S_0188). Green arrows represent core cas genes 
found in all loci, blue arrows represent subtype-specific cas genes, and variable genes not 
previously associated with CRISPRs are shown as black arrows. (B) Genome map with 
annotated CRISPR-cas loci. Boxes indicate locations of individual CRISPR-cas, names 
are shown, as well as CRISPR-cas class type. 
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Figure 3.5 CRISPR-cas loss and the evolution of self-targeting CRISPR spacers in 
non-competent A. actinomycetemcomitans. 
(A) Non-competent strains (red, n = 14) have a lower percentage of intact cas genes than 
competent strains (green, n = 3) (*two-tailed unpaired t-test, P = 0.009). Error bars 
represent standard error of the mean. (B) Non-competent strains’ CRISPRs are enriched 
for self-targeting spacers. Spacer targets were determined by BLASTn analysis [142]. 
The white wedge represents spacers with unknown targets, the black wedge represents 
spacers with known targets. The bar graphs represent the proportion of spacers that are 
known to target self genes (red), phage (blue), plasmids (green).  
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3.2.5 Evolution of CRISPR self gene regulation in non-competent strains 
Despite the fact that non-competent strains have lost many cas genes required for 
immunity, most of these strains maintain one CRISPR with a small number of spacers. A 
current hypothesis is that “broken” CRISPR-cas loci tend toward autoimmunity and 
acquire self-targeting spacers [35] that are used to control expression of chromosomal 
genes. To test this hypothesis, we identified spacers in all strains and predicted their 
targets [90, 143]. Most spacers target unknown sequences (Fig. 3.5B). However, 
identifiable targets in competent strains were predominantly phage and plasmids, while 
strains in non-competent lineages were enriched for spacers with specificity for 
A. actinomycetemcomitans genes (Fig. 3.5B). Some of these self-targeting spacers within 
the non-competent strains are antisense to coding genes, indicating that they could 
regulate self gene expression similar to that observed for an orphan crRNA in Listeria 
monocytogenes [144]. These data suggest that non-competent A. actinomycetemcomitans 
strains are co-opting CRISPRs for A. actinomycetemcomitans chromosomal gene 
regulation, reminiscent of eukaryotic microRNAs that have been co-opted from the RNA 
interference immune surveillance system in higher eukaryotes [145]. To test whether the 
self-targeting CRISPRs could be used for self-gene regulation, we used Northern blot 
analysis to probe for the self-targeting crRNA in A. actinomycetemcomitans VT1169. 
Similar to the orphan CRISPR in L. monocytogenes, the A. actinomycetemcomitans self-
targeting spacer is primarily being expressed during exponential phase growth as part of 
an unprocessed ~650 nt crRNA (Fig. 3.6A). The VT1169 crRNA is antisense to glgP, 
glycogen phosphorylase, and is predicted to bind with perfect complementarity across 35 
nt near the 3’ end of the glgP mRNA (Fig. 3.6B). Further experiments will be required to 
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determine whether crRNA-based gene regulation impacts mRNA stability or translation, 
and if there is a fitness benefit to this recently evolved regulation.  
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Figure 3.6 A. actinomycetemcomitans VT1169 self-targeting crRNA is expressed and 
predicted to target glcyogen phosphorylase mRNA. 
(A) The self-targeting A. actinomycetemcomitans VT1169 crRNA is expressed primarily 
as an unprocessed transcript. Cells were grown to exponential phase (Exp.) and stationary 
phase (Stat.), total RNA was harvested and subjected to Northern blot analysis with a 
probe for the self-targeting crRNA. The ethidium bromide stained rRNA (right panel, top 
2 bands) demonstrates equal RNA loading and RNA integrity. The radiolabeled RNA 
Century Marker-Plus (M) is overexposed at left to serve as the size standard. Northern 
blot is representative of three biological replicates. (B) Predicted binding interaction 
between A. actinomycetemcomitans VT1169 crRNA and the glgP mRNA. 
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3.2.6 An evolutionary model for the effects of competence and CRISPRs on fitness 
We have discovered an instance where bacterial speciation is correlated with 
competence loss and the subsequent loss of bacterial adaptive immunity. While several 
models take into account our results we propose an evolutionary model where 
competence-mediated HGT promotes A. actinomycetemcomitans genetic diversity, while 
non-competence promotes genome stability. Based on this model, dynamic competent 
bacterial genomes quickly drive evolution, benefiting the organism in changing 
environmental conditions. However, non-competent siblings constantly arising in the 
population are selected for when the organisms have beneficial genome content in a 
relatively constant environment. One potential consequence of the concomitant loss of 
CRISPR-cas immunity by these non-competent strains is that they can sample and adjust 
to small changes in the environment through phage and plasmid-mediated HGT. An 
important component of this model is that competent bacteria have more dynamic 
genomes than non-competent strains, consistent with our observations that competent 
bacteria have larger genomes with increased genome rearrangements (Fig. 3.2). While 
this is an appealing model, the selective force(s) that drive loss of competence and 
CRISPR are not known and may not be linked. An alternate model that explains the link 
between CRISPRs and competence is the possible increased susceptibility of competent 
bacteria to genetic parasites relative to non-competent siblings. This is supported by the 
presence of large amounts of extracellular DNA in bacterial biofilms [61, 146], which 
potentially contains parasitic DNA from lysed neighboring cells. This hypothesis is 
bolstered by recent elegant experiments in Streptococcus pneumoniae, whereby an 
artificial CRISPR-cas system prevented natural transformation of a CRISPR-targeted 
capsule gene into a non-virulent rough strain, indicating the CRISPR-cas is capable of 
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preventing natural transformation [147]. Regardless, the evolutionary history of A. 
actinomycetemcomitans reveals a strong correlation between the evolution of competence 
loss and CRISPR adaptive immunity and provides new insights into mechanisms of 
bacterial diversity and speciation.  
 
3.3 MATERIALS AND METHODS 
 
3.3.1 DNA Isolation, genome sequencing, and genome assembly 
A. actinomycetemcomitans 624, Y4, and VT1169 were routinely grown in tryptic 
soy broth supplemented with 0.5% yeast extract, and DNA was purified using standard 
methods for genome sequencing [148]. A. actinomycetemcomitans 624, VT1169, and Y4 
genomes were sequenced and assembled de novo from Roche/454 FLX pyrosequencing 
reads using the Newbler assembler [149] (Table 3.1). Life Technologies SOLiD V4 and 
454 sequencing reads from A. actinomycetemcomitans 624, VT1169, and Y4 were 
aligned to the complete A. actinomycetemcomitans reference genomes 
(A. actinomycetemcomitans HK1651, D7S-1, and D11S-1) using CLC Genomics 
Workbench software (Table 3.1). Supplemental sequencing of VT1169 CRISPR1 was 
carried out by capillary sequencing of a PCR product (C1-For 5’-
ACGCAAATTCACACCCAC-3’ and C1-Rev 5’-TGGATGGTTTTGAGTGAC-3’). 
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3.3.2 Multiple sequence alignments, ANI calculations, and phylogenetic tree 
construction 
 Complete and draft genome sequences for all A. actinomycetemcomitans strains 
were generated in this study or downloaded from Genbank and Oralgen 
(http://www.oralgen.lanl.gov/_index.html) [44, 124-126]. When complete gene 
sequences were not found in the de novo genome assembly of VT1169, consensus gene 
sequences were inferred from alignment to HK1651. The core gene phylogenetic tree was 
constructed from the sequence alignment of 30 concatenated core genes (pyrG, rplA, 
rplB, rplC, rplD, rplF, rplK, rplM, rplP, rplS, rpsC, rpsE, rpsI, rpsJ, rpsM, rpsS, smpB, 
tsf, frr, rplE, rpoB, rpsB, dam, dnaN, dnaQ, holB, holD, recR, rpoA, and rpoH) by the 
Maximum Likelihood method using the Tamura-Nei model in MEGA5 using MUSCLE 
with 100 bootstrap replicates [128-131]. Whole genome alignments were performed with 
progressive MAUVE to identify genome rearrangements, local collinear genomic blocks, 
and variable mobile elements [150]. ANI values for pairwise genome comparison were 
calculated using JSpecies with BLAST (ANIb) and MUMMER (ANIm) [133]. Individual 
competence genes were aligned with MUSCLE in MEGA5 [128, 129, 131]. Whole cas 
operons were aligned with CLC Sequence Viewer. The consensus gene sequences from 
VT1169 sequencing read alignment to HK1651 were used when genes were unassembled 
de novo. 
 
3.3.3 CRISPR detection and characterization 
CRISPRs were identified with CRISPRfinder [151]. CRISPR spacers were 
subjected to BLASTn analyis against the nr/nt database and hits with > 94% identity 
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were recorded [152]. Hits were classified as directed toward plasmid, prophage, phage, or 
self, while negative results were classified as unknowns. 
 
3.3.4 Northern blot analysis 
A. actinomycetemcomitans VT1169 was grown to mid-exponential (OD600 0.80) 
and stationary phase (OD600 1.60) in TSBYE and total RNA was harvested using RNA 
bee (Tel-test), as described previously [153]. Northern blotting was carried out using 
previously described methods [153]. Briefly, 10 µg RNA was separated on an 8% 
polyacrylamide 8 M urea denaturing gel, stained with ethdium bromide, transferred to 
nitrocellulose, UV crosslinked, blocked for 1 h at 55°C in UltraHyb Buffer (Ambion), 
and probed for 16 h at 38.5°C with a radiolabeled DNA oligonucleotide anti-crRNA 
probe (5’GGCGGGTACGGAAGCCTCCGGCACC-3’). The radiolabeled RNA Century 
Marker-Plus (Ambion) was synthesized according to the manufacturer’s protocol and 
served as a size standard. Prior to transfer, gels were stained with ethidium bromide and 
imaged with a G:BOX apparatus (Syngene) to visualize rRNA, which served as the 
loading control. 
 
  
76 
 
Chapter 4. Probing Bacterial Metabolism during Infection using 
High-Resolution Transcriptomics3 
4.1 INTRODUCTION 
Over 100 years ago, Louis Pasteur emphasized the importance of understanding 
the metabolic processes important for bacterial colonization and persistence during 
infection [154]. However, progress in this area has proven challenging in part due to the 
difficulty in characterizing the nutritional content of infection sites. One approach that 
has been successful in probing the growth environment of the infection site is 
transcriptomics using microarrays and RNA sequencing (RNA-seq). Microarrays have 
yielded insights into the carbon sources and metabolic pathways used by pathogens 
during infection [155-158], although these studies are technically challenging due to the 
large amounts of host RNA often present in disease samples. In contrast, high-throughput 
RNA-seq provides a robust tool for global gene expression analyses in vivo since it can 
be performed with low amounts of RNA, and bacterial and host gene expression can be 
separated computationally [159]. However to date, very few in vivo RNA-seq studies 
have been performed for mammalian pathogens. One study revealed significant insight 
into the in vivo physiology of Vibrio cholera during infection [160]; however, the 
undefined media used as an in vitro control limited the conclusions that could be drawn 
about the metabolic pathways active in vivo. 
 
Our laboratory has studied nutrition in numerous pathogenic bacteria including 
the opportunistic human pathogen Aggregatibacter actinomycetemcomitans [14, 22, 161-
                                                
3This Chapter was adapted from the following reference (221, © American Society for Microbiology, 
Journal of Bacteriology, doi:10.1128/JB.00875-13). 
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165]. A. actinomycetemcomitans is a Gram negative, facultative anaerobe that resides in 
the oral cavity of human and old-world primates. Specifically, A. actinomycetemcomitans 
colonizes the subgingival crevice, defined as the area around the tooth bounded by the 
gingival epithelium on one side and the tooth surface on the other. 
A. actinomycetemcomitans is the proposed causative agent of localized aggressive 
periodontitis [166, 167], an acute disease characterized by massive tissue destruction and 
tooth loss. A. actinomycetemcomitans also causes extra-oral infections including abscess 
infections [63, 64, 168], and our laboratory has used a murine abscess infection model to 
characterize A. actinomycetemcomitans genes required for growth in vivo [22]. In this 
study, we utilized high-resolution transcriptomics to examine the physiology of 
A. actinomycetemcomitans during growth in the murine abscess. These analyses revealed 
significant insights into the transcriptional organization of the A. actinomycetemcomitans 
genome including transcription start sites (TSS) and non-coding RNAs (ncRNAs). In 
addition, numerous metabolic genes displaying enhanced transcription during in vivo 
growth were identified. Targeted mutagenesis of these differentially regulated genes 
revealed roles for fermentative metabolism and anaerobic respiration for in vivo 
persistence. 
 
4.2 MATERIALS AND METHODS 
 
4.2.1 Bacterial growth conditions 
A. actinomycetemcomitans strain 624, a rough serotype A clinical isolate was 
used in this study. A. actinomycetemcomitans 624 was routinely cultured in brain heart 
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infusion (BHI) broth or tryptic soy broth supplemented with 0.5% yeast extract (TSBYE) 
shaking at 150 rpm in 5% CO2 atmosphere at 37°C. For mutant A. 
actinomycetemcomitans, BHI and TSBYE were supplemented with 50 µg/ml 
spectinomycin. For RNA-seq, A. actinomycetemcomitans was grown in a chemically 
defined modified Socransky’s medium supplemented with 20 mM glucose, 50 mM 
MOPS, pH 7.2 (CDM) [14, 73], shaking at 150 rpm in 5% CO2 atmosphere at 37°C. Prior 
to biofilm growth, overnight liquid cultures of A. actinomycetemcomitans were diluted 
1:2 with fresh CDM, grown 2 h, centrifuged at >16,000 g, resuspended in CDM, and 
inoculated onto CDM agar plates as colony biofilms [153]. Colony biofilms were grown 
4 hours on CDM agar, transferred to fresh CDM agar for 4 more hours of growth, and 
collected in RNA later solution. 
 
4.2.2 Determining generation times 
Wild-type A. actinomycetemcomitans 624 and the ΔfdhF1F2, ΔfrdABCD, and 
Δpfl mutants were grown shaking at 150 rpm in CDM liquid medium aerobically at 37°C 
in 5% CO2 atmosphere and statically in an anaerobic chamber (Coy). Because 
A. actinomycetemcomitans 624 grows in large aggregates in vitro that cannot be 
adequately dispersed, cellular protein concentrations were determined using a Bradford 
assay (BioRad) to serve as a proxy for cellular growth and calculate generation times. To 
prepare lysates for the Bradford assay, cells were removed throughout exponential 
growth phase, pelleted in a microcentrifuge, resuspended in 6 M urea, and boiled for 30 
m at 100°C to lyse the cells. Generation times were calculated by plotting cellular protein 
concentrations over time. 
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4.2.3 A. actinomycetemcomitans murine abscess infections 
Three-day murine abscess infections were established with wild-type and mutant 
A. actinomycetemcomitans strains, as described previously [22]. Severity of infections 
was determined by plate counts on BHI agar and BHI agar supplemented with 50 µg/ml 
spectinomycin, for wild-type and mutant A. actinomycetemcomitans strains, respectively. 
The experiments described here were conducted according to the Guide for Care and Use 
of Laboratory Animals of the National Institutes of Health. The Texas Tech University 
Health Sciences Center Institutional Animal Care and Use Committee approved the 
protocol (Protocol # 09039). 
 
4.2.4 RNA isolation and high-throughput sequencing library preparation 
A. actinomycetemcomitans biofilm cells stored in RNA later solution were 
centrifuged at 5,000 g, resuspended in 100 µl 10 mg/ml lysozyme in TE buffer and 
incubated for 10 m at 25°C. After lysozyme treatment, 200 µl PBS was added to each 
lysed cell solution and further lysis was carried out by mechanical disruption of each 
sample four times for 30 s at maximum speed in a Mini-Beadbeater (Biospec Products) 
and lysed cell solutions were stored in an ice bath for 2 m in between each bead beating. 
Total RNA was isolated from resulting lysed cells using 1 ml RNA Bee solution (Tel-
Test) according to the manufacturer’s protocol. Murine abscesses were resuspended 
immediately in 1 mL RNA-Bee, bead-beaten 4 times as described above, and RNA was 
purified from pooled abscesses (Table 4.1). DNA contamination in RNA samples was 
removed by treating 5 µg total RNA with 2.5 U RQ1 DNase (Promega) for 30 m at 37°C 
and RNA was purified with 500 µl RNA Bee solution. DNA removal was verified by 
PCR amplification of the A. actinomycetemcomitans clpX protease gene from DNase-
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treated RNA (Table 4.2). Bacterial and host rRNAs were depleted using commercially 
available capture methods (Ambion MICROBExpress and MICROBEnrich kits) or 
enzymatic degradation (Epicentre Terminator 5’-monophosphate-dependent 
ribonuclease) according to manufacturers’ protocols. To produce RNA between 20-500 
nt that is optimal for sequencing, 1 µg rRNA-depleted RNA samples was treated with 
NEBNext RNA fragmentation buffer (NEB). Strand-specific cDNA libraries were 
prepared using commercially available T4 RNA ligase-based kits and sequenced on the 
SOLiD V4 and Illumina HiSeq2000 platforms. Both SOLiD and Illumina cDNA libraries 
were subjected to polyacrylamide gel extraction to purify cDNA between 130-500 nt, 
removing library adapters and primers from the samples. Sequencing library preparation 
kits and sequencing outputs are summarized in Table 4.1. Sequencing reads have been 
deposited in the NCBI Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra), 
accession number SRP022893. 
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Table 4.1 RNA-seq sample and sequencing information. 
Sample1 2rRNA deplete 3Prep Platform 4Total reads 5map 6m/ncRNA 
B1.1 Express NEB (S) SOLiD V4 6,323,061 886,203 85,547 
B1.2 Express NEB (S) SOLiD V4 9,817,673 2,354,500 200,164 
B2.1 Tex NEB (S) SOLiD V4 14,060,736 3,165,547 50,282 
B2.2 Tex Epicentre HiSeq2000 12,632,073 132,635 16,235 
B2.3 NA Epicentre HiSeq2000 8,208,689 557,369 120,289 
A1(6) Enrich NEB (I) HiSeq2000 25,297,104 5,798,615 434,191 
A2(2) Enrich NEB (I) HiSeq2000 42,804,092 25,539,796 839,805 
A3(2) Enrich NEB (I) HiSeq2000 52,165,722 31,983,011 915,676 
1Bx.y: B = biofilm, x = biological replicate, y = technical replicate; A(#): A = abscess, # 
= number of pooled abscesses 
2rRNA depletion method used: Express=Ambion MICROBExpress kit, Enrich=Ambion 
MICROBEnrich kit, Tex=Epicentre Terminator 5’ monophosphate dependent 
exonuclease, and NA=no depletion method was utilized 
3Prep: Library preparation kit used. NEB (S)=NEB Next Small RNA Sample Prep Set 3 
for SOLiD, Epicentre=Epicentre ScriptMiner Small RNA Library Preparation kit, NEB 
(I)=NEB Next Multiplex Small RNA Library Prep Set for Illumina.  
4Total reads: the number of reads sequenced 
5map: the number of reads mapping to the A. actinomycetemcomitans genome 
6m/ncRNA: the number of reads mapping to an mRNA or ncRNA  
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Table 4.2 Primer sequences. 
Primer Sequence (5'-3') 
fdhKO-P1F-USS AAGTGCGGTCCGGTCAGATTCGTACATACAAC 
fdhKO-P1R-Sp CATGTATTCACGAACGAAAATCGAGTAATGTCCTTATTTGAGCTACAAC 
fdhKO-P2F-Sp GAAAACAATAAACCCTTGCATATGATTTAACGAAAATTACAGCCGC 
fdhKO-P2R-USS AAGTGCGGTTGGCTATCTCTAATAAAGTTGGGAG 
fdhKO-verify CTTCAACGCCACTCAATATTTATCC 
frdKO-P1F-USS AAGTGCGGTGCCACCCGTAAATCTTCCG 
frdKO-P1R-Sp CATGTATTCACGAACGAAAATCGGATATTCCTCCAAGTAAAGGGATAG 
frdKO-P2F-Sp GAAAACAATAAACCCTTGCATATGCAACAAAAAACGCCCTCAATG 
frdKO-P2R-USS AAGTGCGGTGACCGCACTTTTGCTAACG 
frdKO-verify CGCTGGTGATTATCCTGTTC 
pflKO-P1F-USS AAGTGCGGTTGGTATCTCCGGCAGAAATG 
pflKO-P1R-Sp CATGTATTCACGAACGAAAATCGAACAAATTATCTACGACCGGGAAAG 
pflKO-P2F-Sp GAAAACAATAAACCCTTGCATATGCAGCCGTTTACCATTTAGGTAAG 
pflKO-P2R-USS AAGTGCGGTGCGACTATTGTAGTGCGCTTTG 
pflKO-verify GAATTCACCCGAACGGGTTATG 
Spec-F CGTTTTTCGTTCGTGAATACATG 
Spec-R CATATGCAAGGGTTTATTGTTTTC 
clpX-F GCAGAAACCATGGCGCGTATG 
clpX-R CAATTCGCTTAATGGCGCCAC 
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4.2.5 Computational methods 
The A. actinomycetemcomitans D7S-1 reference genome (Genbank accession 
ADCF01000001.1) was used for RNA-seq read alignment [125]. The 50 bp single-end 
SOLiD sequencing reads were aligned in colorspace to the reference genome using 
SHRiMP version 2.2.1 to produce sam format read alignment files [169]. The longer 
~100 bp Illumina sequencing reads were pre-filtered using the Flexbar version 2.0 [170] 
to remove library adapter sequences from the sequencing reads (Illumina index 
sequencing primer sequence: 
5’-AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC-3’, Illumina 3’ adapter 
sequence: 5’-TCGTATGCCGTCTTCTGCTTG-3’) and improve alignment to the 
reference genome. Filtered Illumina reads were aligned to the reference using Bowtie 
version 2.0.0 to produce read alignment files in sam format [171]. The read alignment 
files were converted from sam to bam format, sorted and indexed with Samtools [172]. 
Individual read alignments in bam file format from each condition were visualized with 
the Integrative Genomics Viewer (IGV) [173, 174]. Using the read alignments visualized 
with IGV, TSS were manually recorded in GFF format by identifying the position where 
reads aligned upstream of genes. Using an analogous approach, ncRNAs visualized in 
IGV were manually annotated by the identification of reads mapping to intergenic 
regions and antisense to coding sequences. Whole genome annotations for TSS and 
ncRNAs are provided in GFF and Genbank formats with instructions for opening the files 
on our laboratory’s website at 
http://web.biosci.utexas.edu/whiteley_lab/pages/resources.html (DataSetS1.gff and 
DataSetS2.gbk). Prior to determining differential gene expression, read alignment files 
produced by SHRiMP were reformatted for HTSeq read counting with a custom Perl 
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script. The number of reads aligned to each gene and ncRNA in the newly annotated 
reference genome were calculated using HTSeq 
(http://www.huber.embl.de/users/anders/HTSeq), not including tRNAs and rRNAs. Prior 
to calculating differential gene expression, read counts per gene were summed for 
technical replicates, per DESeq recommendation. Differential gene and ncRNA 
expression between A. actinomycetemcomitans biofilms and abscesses were determined 
based on a negative binomial distribution using the R package DESeq version 1.6.1 
[175]. Clusters of orthologous groups (COG) gene enrichment analysis was conducted 
using COGs determined previously [44]. Enrichment of differentially regulated genes in a 
given COG category was determined by comparing the prevalence of up- or down-
regulated genes assigned to a specific COG category and comparing to the prevalence of 
genes in the entire genome assigned to that COG category. Enrichment of a COG 
category in either the up- or down-regulated gene set relative to the genome was 
calculated using a Fisher’s exact test custom macro in Microsoft Excel. Whole genome 
diagrams were produced with Circos version 0.55 [176]. 
 
4.2.6 Construction of A. actinomycetemcomitans deletion mutants 
A. actinomycetemcomitans mutants were constructed for the FDH-H operon 
(fdhF1F2; D7S_2219-D7S_2220), fumarate reductase operon (frdABCD; D7S_1533-
D7S_1536), and pyruvate formate lyase (pfl; D7S_2028) by double homologous 
recombination. Wild-type genes of interest were substituted with aad9 (encoding 
spectinomycin resistance) from pVT1461 by overlap extension PCR and natural 
transformation of A. actinomycetemcomitans 624 [127, 177]. The aad9 spectinomycin 
resistance gene was amplified from pVT1461 using Spec-F and Spec-R to generate Specr. 
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The PCR overlap extension constructs were amplified for the fdhF1F2 operon using 
primers fdhKO-P1F-USS and fdhKO-P1R-Sp to generate the fdhKO-P1 PCR product 
and primers fdhKO-P2F-Sp and fdhKO-P2R-USS to generate the fdhKO-P2 PCR 
product. Overlap extension PCR mixing 500 ng each of fdhKO-P1, Specr, and fdhKO-P2 
with primers fdhKO-P1F-USS and fdhKO-P2R-USS, making the fdhKO PCR product 
containing the ~1 kb region upstream of the fdhF1F2 operon, aad9, and the ~1 kb region 
downstream of the fdhF1F2 operon and A. actinomycetemcomitans specific DNA uptake 
signal sequences on each end to enhance natural transformation. Prior to natural 
transformation, the ~3kb fdhKO overlap extension PCR product was gel extracted using 
a Fermentas gel extraction kit. The fdhF1F2 operon was substituted by natural 
transformation on tryptic soy agar supplemented with 0.5% yeast extract (TSAYE) with 
5% heat inactivated horse serum 1 mM cAMP in an anaerobic chamber via double 
homologous recombination with 1 µg of the fdhKO overlap extension PCR product. The 
resulting ΔfdhF1F2 mutants were selected on TSAYE with 50 µg/ml spectinomycin. The 
ΔfdhF1F2 mutant was verified by growing the mutant in TSBYE with 50 µg/ml 
spectinomycin, purifying genomic DNA using a Qiagen DNeasy kit, and PCR amplifying 
the aad9 gene with the SpecR primer specific to the aad9 gene and the fdhKO-verify 
primer, which anneals upstream of the fdhKO-P1F-USS primer. The verification product 
was observed for ΔfdhF1F2 mutant genomic DNA but not wild-type genomic DNA. 
Analogous methods were used to generate the ΔfrdABCD mutant using primers frdKO-
P1F-USS, frdKO-P1R-Sp, frdKO-P2F-Sp, frdKO-P2R-USS, and frdKO-verify, as well 
as the Δpfl mutant using primers pflKO-P1F-USS, pflKO-P1R-Sp, pflKO-P2F-Sp, 
pflKO-P2R-USS, and pflKO-verify. Primer sequences are available in Table 4.2. 
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4.3 RESULTS 
 
4.3.1 In vitro and in vivo RNA-seq 
The goal of this study was to utilize RNA-seq to provide a high-resolution 
analysis of the A. actinomycetemcomitans genetic elements expressed during in vivo 
growth, with a specific interest in metabolic genes. While A. actinomycetemcomitans is 
most noted for its ability to cause oral infections, our laboratory has utilized an extra-oral 
abscess model to study A. actinomycetemcomitans virulence [22]. We prefer this model 
for the following reasons: A. actinomycetemcomitans causes extra-oral infections, 
including abscess infections, thus the model has clinical relevance [63, 64, 168]; the 
infectious dose is easily controlled and results in a contained infection that has been used 
to study pathogenesis of oral bacteria [22-24]; and unlike periodontal models of infection, 
infected tissue can be easily removed to assess disease severity [22] or for RNA isolation. 
In addition to performing transcriptome analysis in a relevant animal model of infection, 
it is also critical to examine A. actinomycetemcomitans gene expression during in vitro 
growth under defined conditions. Growth under known nutritional conditions is essential 
to provide a well-defined control transcriptome for comparing to the undefined in vivo 
transcriptome. Therefore, we grew A. actinomycetemcomitans as a colony biofilm on a 
solid defined medium with glucose as the sole energy source. Since glucose metabolism 
is well characterized and A. actinomycetemcomitans forms robust biofilms, this growth 
condition provided a well-defined, relevant control for the in vivo experiments. 
 
Total RNA was harvested from biofilms and abscesses and strand-specific cDNA 
libraries were subjected to RNA-seq analysis. Because murine abscesses contain small 
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populations of bacteria (approximately 106 bacteria per abscess) it was essential to 
develop methodology to efficiently purify RNA from the infections, deplete the abundant 
murine ribosomal RNA, and enrich for bacterial transcripts in order to obtain sufficient 
bacterial sequencing reads for analysis. Since sequencing technologies are constantly 
evolving, we used two sequencing platforms to quantify transcript levels. However, it is 
important to note that all sequencing libraries were prepared using similar RNA ligation-
based protocols and each technology produces reads of sufficient length to map 
specifically to reference genomes. For both technologies, gene expression data was 
normalized among all replicates for differential expression analyses. The resulting 
sequencing reads were processed and aligned to the A. actinomycetemcomitans genome 
to determine the A. actinomycetemcomitans transcriptome during in vitro and in vivo 
growth. In total, 7.1 million biofilm and 63.3 million in vivo sequencing reads were 
aligned to the A. actinomycetemcomitans genome (Table 4.1) resulting in an average of 
~190 and 870 reads/gene for in vitro and in vivo grown A. actinomycetemcomitans, 
respectively. Using these data we manually annotated A. actinomycetemcomitans TSS 
and ncRNAs. Differential expression of protein-coding genes and ncRNAs was 
determined after normalizing for read number to identify in vivo regulated genes. 
 
4.3.2 Transcription start site mapping 
To begin characterizing the primary transcriptome of A. actinomycetemcomitans, 
TSS were manually annotated using the aligned RNA-seq data (as detailed in the 
‘computational methods’ section of the Materials and Methods). TSS were identified by 
manually recording the position where reads aligned upstream of annotated genes using 
IGV [173, 174]. In total, 691 mRNA TSS were identified in A. actinomycetemcomitans 
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(Fig. 4.1). Among the TSS, several previously characterized TSS including katA, apiA, 
and lysT were verified by our RNA-seq analyses, thus validating our approach [16, 153]. 
Due to the methods used to generate the RNA-seq libraries, it is important to note that the 
TSS identified represent authentic TSS as well as the 5’ ends of processed RNAs. 
However, most bacterial transcripts are not specifically processed at a defined nucleotide 
but are processively degraded [178]. Moreover, since several of the TSS identified here 
correspond with TSS identified by other approaches [16, 153], many of these TSS likely 
represent true start sites. 
 
Secondary TSS have been observed among genes in Helicobacter pylori and in a 
cyanobacterium, but the roles of alternate TSS are relatively obscure [179, 180]. When 
TSS for genes differ from one growth condition to another, it suggests that the gene is 
transcribed from multiple promoters or the mRNA is differentially processed. We 
observed 11 genes with different TSS in vivo and in vitro (Fig. 4.1). One potential 
hypothesis is that alternative promoters are used to differentially regulate genes during in 
vivo and in vitro growth; however, 9 of the 11 genes were not differentially expressed 
suggesting that the utilization of alternate promoters does not correlate with differential 
regulation.  
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Figure 4.1 A. actinomycetemcomitans mRNA 5’ ends and 5’ end switching in vivo.  
(A) A. actinomycetemcomitans 5’ ends mapped along the genome to the positive strand 
(outer circle, black) and negative strand (inner circle, red). The putative origin of 
replication is marked by dnaA. Locus tags for genes with different start sites in vivo and 
in vitro are marked along the outermost circle and colored according to read strand. 
(B) Genes with different start sites in vivo. Locus tags for genes are indicated, significant 
differences in mRNA expression (fold-change) during in vivo growth are listed below the 
locus tags, the location of the in vivo TSS relative to the in vitro TSS, and the gene 
function follow. When no fold-change is indicated, genes were not differentially 
expressed in vivo. 
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4.3.3 A. actinomycetemcomitans ncRNA discovery 
RNA-seq provides tremendous insight into the identification and potential 
functions of ncRNAs transcribed from intergenic regions and antisense to coding genes. 
Like TSS and operons, ncRNAs were identified based on contiguous reads aligning to 
intergenic regions and antisense to protein-coding genes observed in IGV (Fig. 4.2). The 
ncRNA sequences were collected and compared to the Rfam database to determine 
homology to ncRNAs characterized in other bacteria [181, 182]. In biofilms and in vivo, 
A. actinomycetemcomitans expressed a number of ncRNAs, including riboswitches, cis-
anstisense RNAs (asRNAs), small ncRNAs (sRNAs), and clustered regularly interspaced 
short palindromic repeat RNAs (crRNAs) (Fig. 4.2). In total, A. actinomycetemcomitans 
expressed 210 ncRNAs, including 127 asRNAs, 3 pre-crRNAs, 3 riboswitches, 75 
sRNAs, and 1 unidentified tRNA. Among these ncRNAs were housekeeping ncRNAs 
involved in transcription, translation, and protein secretion (Table 4.3), and several 
previously discovered and predicted ncRNAs [183-189]. In addition, many ncRNAs were 
differentially expressed in vivo compared to in vitro biofilm growth. Indeed, 80 out of 
210 ncRNAs were differentially expressed in vivo, including 39 up-regulated and 41 
down-regulated ncRNAs (Fig. 4.2). This result is significant, but perhaps expected, since 
the roles of ncRNAs for in vivo growth and persistence has been described for other 
bacteria [190-192].  
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Figure 4.2 A. actinomycetemcomitans ncRNAs are differentially regulated in vivo. 
A. actinomycetemcomitans ncRNAs mapped along the genome to the positive strand 
(outer circle) and negative strand (inner circle). ncRNAs are colored according to type: 
sRNA (red), asRNA (blue), riboswitch (green), and pre-crRNA (light blue). The circular 
histogram indicates the log2 fold-change of ncRNA expression in vivo (-10 to 10, inner to 
outer line). Bars are colored relative to change in ncRNA expression, > 2-fold up-
regulated (yellow), > 5-fold up-regulated (red), > 2-fold down-regulated (light blue), > 5-
fold down-regulated (purple), and no change (grey). 
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Table 4.3 Rfam predictions for A. actinomycetemcomitans ncRNAs. 
 Rfam predictions 
Locus tag Start Stop Strand RNA family Start End E-value 
D7S_0043.1 41437 41836 + sRNA, RNaseP A 2 390 4.91E-40 
D7S_0235.1 240380 240648 - sRNA, GcvB 18 174 8.90E-23 
D7S_0343.1 340697 340887 + sRNA, tfoR 91 181 5.10E-03 
D7S_0661.1 640001 640182 + sRNA, his leader 42 171 4.28E-17 
D7S_0743.1 704845 704936 - tRNA 2 74 5.29E-14 
D7S_0849.1 794824 795016 - sRNA, 6S RNA 1 184 1.52E-23 
D7S_1442.2 1323184 1323273 - sRNA, C4 1 74 4.90E-12 
D7S_1454.1 1330343 1330779 - sRNA, tmRNA 1 366 7.92E-92 
D7S_1607.1 1477807 1477998 - riboswtich, FMN riboswitch 1 182 5.17E-29 
D7S_1716.1 1572027 1572259 - riboswitch, glycine riboswitch 87 231 1.00E-10 
D7S_2270.1 2096164 2096331 + sRNA bacterial SRP 47 145 2.08E-18 
Nucleotide sequences were collected for ncRNAs and searched against Rfam database 
families (RNA family). Locus tags are in Table S3. Start and stop refer to the location of 
the ncRNA on the A. actinomycetemcomitans reference genome. The portions of the A. 
actinomycetemcomitans ncRNA sequences that possessed sequence homology to RNAs 
in the Rfam database are indicated (Start and End), as well as the Expectation value 
(E-values).  
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4.3.4 Fermentative metabolism and anaerobic respiration promote in vivo survival 
Our main goal was to use RNA-seq to identify metabolic pathways that impact 
A. actinomycetemcomitans fitness in vivo. The hypothesis was that genes differentially 
regulated in vivo will be enriched for those important for growth in the murine abscess. 
To identify differentially regulated genes, in vitro and in vivo transcriptomes were 
compared. This analysis yielded 337 genes (~14% of all predicted genes) that were 
differentially regulated 2-fold or greater (Fig. 4.3A) in the abscess infection relative to 
the in vitro biofilm. Of these genes, 107 were differentially regulated 5-fold or greater. 
Notably, genes encoding the A. actinomycetemcomitans virulence factors leukotoxin 
(locus tag D7S_0615) and cytolethal distending toxin (locus tag D7S_2348) [37-40, 193] 
were up-regulated in vivo. While leukotoxin is upregulated in low oxygen conditions 
[193], prior to this study, neither toxin was known to be up-regulated during infection. 
 
To gain a broader perspective of genes differentially regulated in vivo, we 
performed an enrichment analysis to define clusters of orthologous groups (COGs) [194, 
195] for differentially regulated genes. This analysis first clusters genes based on their 
putative function then examines whether a particular category is enriched for 
differentially regulated genes compared to what would be expected by chance. Using the 
COGs defined by Kittichotirat et al. [44], only one COG category (COG C) was 
significantly enriched for both up- and down-regulated genes. COG C includes genes 
involved in energy production and conversion (Fig. 4.3B), suggesting that 
A  actinomycetemcomitans undergoes substantial changes in metabolism during in vivo 
growth.  
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Figure 4.3 Differential RNA-seq and COG enrichment analyses reveal the 
importance of energy metabolism in vivo. 
(A) In vivo differential gene expression plot. Fold-change for each gene in vivo is plotted 
against mean gene expression. Red points represent the 337 genes with significant 
differential gene expression in vivo (P < 0.05, DESeq). (B) In vivo COG enrichment 
analysis. Enrichment of COGs among differentially regulated genes compared to the 
abundance of the COGs in the genome was determined using Fisher’s exact test (P < 
0.05). 
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Included within the differentially regulated metabolic genes were operons 
encoding formate dehydrogenase H (fdhF1F2) and fumarate reductase (frdABCD), which 
are involved in fermentative metabolism and anaerobic respiration, respectively 
(Fig. 4.4). Thus we hypothesized that these operons would be important for A. 
actinomycetemcomitans growth in the murine abscess. To test this hypothesis, individual 
mutants containing deletions of fdhF1F2 or frdABCD were constructed via allelic 
exchange. In addition, a strain containing a deletion of the gene encoding pyruvate 
formate lyase (pfl) was also constructed. Since pfl was not differentially regulated in vivo, 
we hypothesized that it would not be critical for A. actinomycetemcomitans growth in the 
abscess; thus this mutant served as a control for subsequent in vivo experiments.  
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Figure 4.4 Metabolic genes and pathways up-regulated in vivo. 
Genes putatively encoding fructose, glucose, mannose, and ribose transporters were up-
regulated in the murine abscess along with multiple fermentative and anaerobic 
respiratory pathways. (red: > 5-fold up-regulated, yellow: > 2-fold up-regulated, grey: no 
change). Dashed lines indicate genes/pathways selected for mutagenesis. TMAO 
(trimethylamine-N-oxide), TMA (trimethylamine), DMSO (dimethylsulfoxide), DMS 
(dimethyl sulfide), FDH (formate dehydrogenase), ETC (electron transport chain). 
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Figure 4.5 Metabolic mutants are attenuated in vivo. 
Monoculture abscess infections with wild-type, ΔfdhF1F2, ΔfrdABCD, and Δpfl strains 
were processed 3 days post-infection and CFU/abscess were determined by plate counts 
(*P < 0.05, Mann-Whitney U Test, compared to wild-type). Each symbol represents 
infection of an individual mouse. 
  
98 
 
Abscesses produced by both the ΔfdhF1F2 and ΔfrdABCD mutants contained 
~10-fold less bacteria than wild-type infections (Fig 4.5), indicating that these pathways 
are critical for A. actinomycetemcomitans fitness in the murine abscess. In contrast, the 
Δpfl mutant showed similar bacterial numbers to wild-type A. actinomycetemcomitans 
(Fig. 4.5). Importantly, deletion of fdhF1F2 and frdABCD operons did not impact aerobic 
or anaerobic in vitro growth in a glucose defined medium (data not shown). Collectively, 
these data suggest that the fdhF1F2 and the frdABCD operons are not only highly up-
regulated during in vivo growth but also impact A. actinomycetemcomitans fitness in the 
murine abscess. 
 
4.4 DISCUSSION 
In this study, a high-resolution transcriptome analysis was performed for in vitro 
and in vivo grown A. actinomycetemcomitans using RNA-seq. Protocols were developed 
to isolate total RNA from abscess infections and enrich for bacterial RNA before RNA-
seq analysis. From these data, the terminal 5’ sequences of ~700 RNAs were mapped, 
most of which likely represent authentic transcriptional start sites. In addition, over 300 
A. actinomycetemcomitans genes were shown to be differentially regulated during 
abscess infection as compared to in vitro grown bacteria. This study provides the first 
high-resolution transcriptome analysis of a bacterium during growth in an abscess and 
establishes methodology for performing RNA-seq on samples containing predominantly 
host RNA. 
 
The primary goal of this work was to identify metabolic pathways utilized by 
A. actinomycetemcomitans in vivo by focusing on metabolic genes differentially 
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regulated during growth in the abscess. The use of defined in vitro growth conditions 
provided a robust control to probe A. actinomycetemcomitans metabolism during in vivo 
growth, allowing identification of both fermentative and respiratory pathways important 
for A. actinomycetemcomitans growth in the murine abscess (Fig. 4.4). The enrichment of 
pathways, including fdhF1F2 and frdABCD, primarily involved in regeneration of NAD+ 
during anaerobic growth, suggests that A. actinomycetemcomitans experiences low 
oxygen in the abscess. This observation is curious in regard to previous studies from our 
group demonstrating that during co-culture infection with the peroxigenic oral bacterium 
Streptococcus gordonii, A. actinomycetemcomitans grows aerobically in the abscess [22]. 
Why the A. actinomycetemcomitans-S. gordonii co-culture abscess infection is aerobic is 
currently unknown, but these results emphasize that a pathogen may require distinct 
metabolic pathways to persist in an infection site dependent on whether it is alone or in 
the presence of other microbes. Of course the infection site may also impact gene 
expression, and it will be interesting to examine A. actinomycetemcomitans gene 
expression in the oral cavity during mono- and co-culture. 
 
One of the primary advantages of RNA-seq is that it provides unparalleled insight 
into ncRNAs expressed in a given growth condition. Here we reported the differential 
regulation of 80 A. actinomycetemcomitans ncRNAs and increased expression of hfq in 
vivo. The up-regulation of hfq is particularly striking since it encodes an sRNA chaperone 
that promotes ncRNA interactions with mRNA targets [196, 197]. Similar to other 
studies, this suggests that A. actinomycetemcomitans ncRNAs may play important 
regulatory roles in vivo [190, 191, 198]. Differential regulation of ncRNAs also provided 
insight into the nutritional content of the infection site. For example, the 
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A. actinomycetemcomitans lysine riboswitch and the sRNA GcvB [114, 117, 153] 
showed reduced abundance during infection. These ncRNAs regulate expression of lysine 
and glycine transport proteins respectively, and their decreased levels suggest that these 
amino acids are found at reduced levels in the abscess. 
 
Transcriptome analysis using RNA-seq is a powerful and sensitive tool for 
studying infectious disease processes in vivo. Development of methodologies for 
performing RNA-seq on in vivo samples dominated by host RNA allowed tremendous 
insight into the physiology and metabolism of A. actinomycetemcomitans during in vivo 
growth. As evidenced by the abscess CFU counts, the methodology employed here can 
be used to perform gene expression analyses on as few as 105 in vivo bacteria. Ultimately, 
applying this technology to defined polymicrobial infections, as well as undefined 
complex human infections, will provide a window into the physiology of bacterial 
pathogens in human infections. 
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Chapter 5. Gene Expression of the Human Microbiome during Health 
and Disease 
5.1 INTRODUCTION 
Periodontal disease is a “microbial shift” disease associated with massive 
reorganization of the microbiota residing in the subgingival crevice, the region between 
the tooth surface and the gingival epithelium [6]. Studies using culture-independent 
methods have shown that the presence and prevalence of certain species or genes in the 
microbiome are correlated with disease [6, 199-202]. In light of these results, 
microbiome-associated diseases such as periodontitis are increasingly examined through 
an ecological lens. Yet as communities occupying various niches throughout the human 
body shift into a diseased state, it is unclear how the behavior of the microbiota changes 
during disease. Thus the question arises, to what extent are changes in the ecosystem 
attributable to alterations in the abundance of certain community members or changes in 
the behavior of existing organisms? Recent advances in high-throughput sequencing have 
greatly accelerated the cataloging of changes to the organismal and metagenomic content 
of microbial communities in health and disease [203, 204], and they also provide an 
avenue to analyze the behavior of the community and its constituent members. In this 
study, we used massively parallel RNA sequencing to profile changes in both the 
composition and gene expression of the human microbiome in periodontitis. 
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5.2 RESULTS AND DISCUSSION 
 
5.2.1 Quantifying microbiota with qrRNA-seq 
Patient-matched healthy and diseased periodontal samples were collected from 10 
patients with aggressive periodontitis (Table 5.1). Quantification of rDNA has been used 
to identify different bacterial species correlated with periodontal disease or health [6]; 
however, these studies also likely captured extracellular DNA, an important structural 
component of surface attached biofilms [205, 206]. Moreover, these studies do not 
differentiate between metabolically active and dead cells. Since rRNA content is 
proportional to growth rate [207], direct rRNA quantification provides a measurement of 
metabolic activity of individual members of the community. To this end, we developed 
quantitative rRNA sequencing (qrRNA-seq). Our qrRNA-seq method sequences two 
adjacent variable regions of the 16S rRNA of bacterial ribosomes, aligns these to the 
Greengenes rRNA database [208], and quantitates ribosomal RNA using Qiime 
[209](Table 5.2). Similar to studies that used rDNA-based procedures [5, 6], we found 
that many bacteria are present in both healthy and diseased communities; however, our 
data indicated that many of the most metabolically active microbes in disease samples 
were those previously associated with infection, including Tannerella sp., Prevotella sp., 
Treponema sp., and Porphyromonas sp. (Fig. 5.1).  
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Table 5.1 Aggressive periodontitis patient data. 
        Mean PD1 per sampling site 
Sample Age Gender PD(full)1 CAL(full)2 Plaque 
Bleeding 
(%) Smoking Disease Healthy 
1 34 F 6.5 6.5 1 60 no 5 3 
2 36 M 6 7 2 80 yes 5 3 
3 30 F 5 5 2 70 yes 6 2 
4 34 M 5 6.5 1 70 no 5 2 
5 36 M 5 6 2 90 yes 5 2 
6 40 F 5 5 1 60 no 5 3 
7 34 M 5.5 5.5 1 70 no 7 2 
8 33 F 6 6 2 70 yes 6 2 
9 36 F 5.5 5.5 2 80 no 5 2 
10 37 F 5 5 1 60 no 5 3 
1PD: Probing depth of the subgingival crevice (mm) 
2CAL: Clinical attachment loss of gingival epithelium (mm) 
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Table 5.2 qrRNA-seq sequencing and analysis information. 
Sample Total reads1 Assembled reads2 Assigned OTUs3 
D1 168,406 31,314 28,421 
D2 171,933 40,849 36,916 
D3 165,777 26,637 23,416 
D4 179,507 35,624 32,597 
D5 167,569 29,838 27,126 
D6 157,970 46,462 42,953 
D7 154,688 35,032 32,334 
D8 146,168 38,447 35,263 
D9 151,182 20,432 18,009 
D10 180,610 42,818 39,229 
H1 148,195 17,022 16,629 
H2 106,273 17,308 15,087 
H3 175,362 26,423 23,775 
H4 128,998 5,520 5,008 
H5 140,917 8,690 7,836 
H6 144,023 7,928 7,314 
H7 167,730 19,677 18,032 
H8 180,986 7,308 6,565 
H9 189,386 17,090 15,302 
H10 167,501 12,443 11,300 
1Total paired MiSeq sequencing reads. 
2Number of reads assembled into contiguous 16S rRNA V4/V5 
regions. 
3Number of assembled reads that were assigned to operational 
taxonomic units (OTUs). 
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Figure 5.1 Average bacterial species abundances in healthy and diseased 
periodontal samples determined by qrRNA-seq. 
(a) qrRNA-seq was used to determined OTUs present in health and disease. Shown are 
average abundances for healthy (blue) and diseased (red) samples. Error bars indicate 
s.e.m. (n = 10). (b) OTU abundances for healthy and diseased samples from patients 5, 6, 
and 8, which were selected for metaRNA-seq. 
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5.2.2 Diseased communities are less diverse than healthy communities 
Since qrRNA-seq provides a quantitative assessment of ribosomes from 
individual species within the community, it allows assessment of the overall metabolic 
activity of each member of the population. Examination of ribosome content in healthy 
and diseased populations showed that diseased samples had significantly lower alpha 
diversity, or within-population diversity, than healthy populations (Fig. 5.2a). In addition 
to having fewer metabolically active species, the most prevalent members of diseased 
populations contributed more highly to overall rRNA content than prevalent species in 
healthy populations (Fig. 5.2b). These data together with a previous study [6] support a 
model wherein aggressive periodontitis is marked by the bloom of pre-existing 
pathogenic species that out-compete rare microbiota. Beta diversity analysis comparing 
the relatedness of diseased and healthy populations from multiple individuals showed that 
diseased populations clustered together tightly around the average disease state (Fig. 5.3). 
Moreover, diseased populations were more related to this average state than to paired 
healthy populations from the same individual. This did not hold true for healthy 
populations, which appeared to have a more random rRNA composition, as demonstrated 
by their scattered distribution in the multidimensional scaling plot (Fig. 5.3). These data 
show that healthy periodontal populations are diverse, patient-specific, and contain a 
large population of rare active microbiota, while a few commonly found, highly prevalent 
active organisms overwhelm rare healthy microbiota during aggressive periodontitis.  
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Figure 5.2 Ribosome quantification reveals that diseased periodontal microbiota are 
less diverse and contain fewer low abundance species than healthy populations. 
(a) Number of distinct 16S rRNA sequences (operational taxonomic units, OTUs) 
observed in healthy (blue) and diseased (red) samples with increasing numbers of 
sequences sampled from each population. Error bars indicate S.E.M. (n = 10). 
(b) Number of OTUs contributing to the total population in healthy (blue) and diseased 
(red) samples. OTUs for each population were sorted from highest abundance to lowest 
and the running percentage was calculated for each additional OTU. OTUs at the Domain 
level were ignored. Grey bars indicate S.E.M. (n = 10). Orange line indicates point at 
which diseased OTUs contribute to a significantly greater percentage of the population 
than the healthy OTUs (P < 0.05, unpaired two-tailed Student’s t-test). 
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Figure 5.3 Diseased oral microbial populations have similar population composition. 
Beta diversity was measured using the unweighted Unifrac method to calculate 
relatedness of paired healthy (blue) and diseased (red) microbial populations by 
assessment of shared and unique species in each community. Principle coordinates 1 and 
2 are plotted. Mean diseased and healthy centroids (mean + S.D.) are indicated by 
ellipses. Distances between samples and corresponding centroids are shown as blue and 
red lines, respectively. Black lines show distances between paired populations from the 
same patient. The table summarizes the mean distance (mean ± S.D.) from each sample 
to corresponding centroids and corresponding paired sample from the same patient (P, 
unpaired two-tailed Student’s t-test). 
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5.2.3 Quantifying gene expression with metaRNA-seq 
Changes in the composition of the microbiome have previously been associated 
with numerous diseases, including periodontitis, and the results of our qrRNA-seq 
analysis show that specific members of the community metabolically dominate during 
periodontal disease. Yet it remains unclear whether the behavior of the microbiota also 
changes during disease. To address this question, we used high-resolution community 
transcriptional profiling, which we have termed metaRNA-seq. Total RNA was extracted 
from patient-matched healthy and diseased samples, depleted of highly abundant human 
and bacterial rRNA, and sequenced on an Illumina HiSeq. In total, 1.5 billion metaRNA-
seq reads were sequenced (Table 5.3). The majority (> 99%) of reads were of bacterial 
origin, as determined by alignment to the oral microbiome [210], human cDNA, and the 
viral genome databases (Table 5.4). To quantify gene expression, reads were aligned to a 
60-organism “metagenome”, representing microbes comprising 60-90% of total healthy 
or diseased rRNA. Since we characterized both healthy and diseased communities from 
the same patient with metaRNA-seq, we could analyze differential expression of 
>160,000 bacterial genes simultaneously between health and disease. For each sample, 
28-85 million metaRNA-seq reads mapped to the 60-organism metagenome, representing 
an average coverage of ~170 reads per gene. 
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Table 5.3 metaRNA-seq sequencing information. 
Sample Total reads1 Trimmed reads2 Mapped3 
D5 140,019,932 113,647,258 55,160,160 
D6 190,430,010 160,583,365 70,164,137 
D8 246,462,918 179,248,020 71,603,870 
H5 261,039,989 90,831,243 34,054,085 
H6 265,255,404 72,454,286 28,207,802 
H8 199,443,355 156,541,929 85,709,824 
1Total reads sequenced from each sample. 
2Reads remaining after adapter removal. 
3Total reads aligned to the 62-organism metagenome. 
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Table 5.4 Percent specific metaRNA-seq reads aligned to the HOMD database, 
human mRNA database, and viral genome database. 
 Sample 
Database D5 D6 D8 H5 H6 H8 
HOMD 99.9999% 99.9999% 100.0000% 99.9632% 100.0000% 100.0000% 
Human 0.0001% 0.0000% 0.0000% 0.0002% 0.0000% 0.0000% 
Virus 0.0000% 0.0001% 0.0000% 0.0366% 0.0000% 0.0000% 
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5.2.4 Communal shift toward amino acid consumption 
Previous studies have used genomic information to predict disease-associated 
shifts in metabolism; however these studies are based on the genetic capacity of the 
population rather than expression of metabolic genes [211, 212]. Our metaRNA-seq 
approach allows, for the first time, modeling of the metabolism of the microbiome during 
health and disease based solely on differential gene expression. In this approach, we used 
Enzyme Commission (EC) numbers to assign biochemical function to the >160,000 
genes present in the 60-organism metagenome. EC numbers classify enzymes based on 
the reaction that they catalyze (i.e. enzymes catalyzing the same reaction will have the 
same EC number). This allowed us to calculate changes in expression of metabolic 
enzymes for the entire community during health and disease, resulting in a quantitative, 
high-resolution view of metabolism. Among ~1100 unique enzyme-coding gene families 
in the oral metagenome, ~18% were differentially expressed (P < 0.05) at the 
microbiome level during disease (Fig. 5.4). Differentially expressed gene families were 
mapped to the Kyoto Encyclopedia of Genes and Genomes [213] metabolic pathway 
database to reveal enzymatic steps whose genes were up-regulated, down-regulated, or 
unchanged in the microbiome during disease (Fig. 5.5). Many enzyme-coding genes 
related to amino acid metabolism were up-regulated, including pathways involved in 
lysine and histidine degradation as well as genes involved in butyrate production. These 
results suggest that histidine and lysine consumption by the disease-associated 
microbiome is important during aggressive periodontitis. This is further supported by up-
regulation of numerous protease genes during disease, which degrade extracellular 
proteins and liberate amino acids [214-216] (Fig. 5.6a, Table 5.5). 
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Figure 5.4 Differential expression of enzyme gene families in health and disease. 
Log2 fold-change during disease is plotted against the log2 mean read counts per million 
total reads for each EC enzyme-coding gene family. Gene families up-regulated in health 
are shown in blue, while gene families up-regulated in disease are shown in red.  
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Figure 5.5 Differential metabolic gene expression in the diseased periodontal 
microbiome. 
Metabolic network reconstruction. Black lines indicate enzyme-coding genes that were 
expressed and unchanged in health and disease, red lines indicate up-regulated genes 
during disease, and blue lines indicate up-regulated genes during health. Orange labels 
identify different regions of the metabolic pathway map. Those highlighted in yellow 
represent whole pathways that were up-regulated in disease. THF: tetrahydrofolate 
metabolism.  
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Figure 5.6 The microbiome alters behavior during periodontal infection. 
(a) Although less than 10% of the microbiota in diseased and healthy communities, the 
keystone species F. nucleatum mediates enhanced lysine fermentation in diseased 
communities to produce butyrate. Butyrate is present at high levels in periodontal disease 
and prevents gingival fibroblast growth. T. forsythia enhances expression of the protease-
encoding gene prtH, which likely liberates amino acids in diseased sites. Locus tags are 
indicated for each enzyme-coding gene, and the fold-change in gene expression at the 
community level during disease is indicated below each locus tag. (b) Relative 
abundance of Fusobacterium sp. and Tannerella sp. rRNA during health and disease. 
Relative abundances were determined using qrRNA-seq (Extended Data Fig. 1b). 
(c) Differential gene regulation of T. forsythia in diseased sites. Log2 fold-change in gene 
expression during disease is plotted against log2 mean read count per million reads (n=3). 
(d) Differential gene regulation of F. nucleatum in diseased sites. Graph is depicted as in 
(c). 
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Table 5.5 Virulence factors are up-regulated during disease due to differential gene 
regulation and change in population composition. 
Species Locus ID 
Gene 
FC* 
rRNA 
FC† 
Gene 
P-value‡ Gene/product§ 
Tannerella forsythia BFO_1352 53 13 3.37E-04 Collagenase 
Tannerella forsythia BFO_1417 15 13 1.49E-02 prtH, protease 
Tannerella forsythia BFO_2000 34 13 1.10E-02 bspA, bacterial group 2 Ig-like protein 
Porphyromonas gingivalis PG_0026 3 1 2.68E-01 Gingipain 
Porphyromonas gingivalis PG_0506 3 1 4.68E-01 Gingipain, arginine-specific cysteine 
proteinase 
Porphyromonas gingivalis PG_1542 2 1 5.13E-01 Collagenase 
Porphyromonas gingivalis PG_2024 16 1 9.94E-02 hagE, hemagglutinin protein HagE 
Fusobacterium nucleatum FN1668 37 1 2.92E-06 Cholinephosphate cytidylyltransferase, LPS 
modification 
Fusobacterium nucleatum FN1669 15 1 1.65E-04 Choline transport protein, LPS modification 
Fusobacterium nucleatum FN1670 4 1 2.47E-02 Choline kinase, LPS modification 
Prevotella tannerae ptan_c_1_1221 5 19 9.11E-02 prtC, Collagenase 
Prevotella intermedia PIN17_0033 11 4 1.32E-02 inpA, interpain A peptidase C10 family 
protein 
*Fold-change in gene expression at the community level during disease. 
†Fold-change in rRNA levels during disease. 
‡P-value for change in gene expression at the community level during disease. 
§Gene product description. 
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5.2.5 The keystone species F. nucleatum delays wound healing through differential 
gene expression of lysine fermentation genes 
The observed metabolic changes in the diseased community could have resulted 
from either increased abundance of organisms carrying out those processes or differential 
gene regulation by individual organisms during infection. Our high-resolution 
metaRNA-seq analyses allow differentiation of these two possibilities through analysis of 
gene expression of individual species during health and disease. These analyses showed 
that the Gram-negative organisms Fusobacterium nucleatum and Tannerella forsythia 
were primary sources of metabolic gene expression changes in the diseased community 
(Fig. 5.5 and 5.6a). Increased expression of T. forsythia genes in the diseased community 
could be attributed to both changes in abundance of this bacterium (i.e. changes in gene 
expression were equivalent to abundance changes, prtH in Fig. 5.6bc and Table 5.5) and 
differential gene expression. In contrast, F. nucleatum maintained constant relative 
abundance in both healthy and diseased communities (Fig. 5.6b), yet highly up-regulated 
many genes, including those involved in lysine fermentation to produce butyrate 
(Fig. 5.6d). Butyrate production has been observed at high levels in infected periodontal 
sites [217] and inhibits growth of gingival fibroblasts [218], thus potentially delaying 
wound healing. Therefore, F. nucleatum likely plays an important role in disease 
exacerbation and delayed healing via butyrate production. We propose F. nucleatum is a 
keystone species during periodontitis, functioning not by changing its prevalence during 
disease but by shifting metabolism of the community to produce a metabolite known to 
be important for maintaining the diseased state. 
 
This study provides the first differential gene expression analysis of the human 
microbiome during health and disease. Using high-resolution transcriptomics combined 
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with microbiome community analyses, we have shown changes in both composition and 
gene expression of the microbiome during disease. Furthermore, our results emphasize 
the importance of studying behavior of the microbiome during disease, since constant-
abundance species, like F. nucleatum, can differentially regulate pathways that have a 
profound impact on infection.  
 
5.3 METHODS 
 
5.3.1 Study population 
A total of 10 individuals seeking dental treatment in the School of Dentistry, Ege 
University, İzmir, Turkey, were involved in the present study. Systemically healthy, 
untreated 10 patients with generalized aggressive periodontitis (AgP) were recruited from 
September 2011 to August 2012 (Table 5.1). The study was conducted in full accordance 
with ethical principles, including the World Medical Association’s Declaration of 
Helsinki, as revised in 2000. The study protocol was explained, and written informed 
consent was received from each individual before clinical periodontal examinations and 
subgingival plaque sampling. Medical and dental histories were obtained and smoking 
habits were recorded. Individuals with medical disorders, such as diabetes mellitus, 
immunological disorders and those who had antibiotic or periodontal treatment in the last 
6 months were excluded from the study. 
 
Individuals with AgP were diagnosed in accordance with the clinical criteria 
stated in the consensus report of the World Workshop in Periodontitis. Individuals had at 
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least 6 permanent teeth, including incisors and/or first molars, with at least one site with 
probing depth (PD) and clinical attachment loss (CAL) ≥ 5 mm and 6 teeth other than 
first molars and incisors with similar PD and CAL measurements, familial aggregation 
(all individuals were asked if they had any family member with current or history of 
severe periodontal disease).  
 
5.3.2 Subgingival plaque sampling 
For the diseased samples, the deepest 3 pockets were selected and pooled in a 
single eppendorf tube. Supragingival plaque was first removed from the sample teeth 
with sterilized Gracey curettes and sterilized gauze. The site was then cleaned and 
isolated using cotton roles and air dried gently. Another sterilized Gracey curette was 
inserted to the deepest part of the pocket and removed applying a slight force towards the 
root surface. The tip of the curette was then inserted in the eppendorf tube containing 
RNA Later and shaken until the plaque was removed from the curette. For the healthy 
subgingival plaque samples, in the same patient 3 healthy sites that did not show any sign 
of inflammation and bleeding on probing were chosen and pooled in an eppendorf tube. 
The same procedures were followed for the subgingival sampling. After 24 h, the 
samples were frozen and stored at -40oC until the sample collection period was 
completed. 
 
5.3.3 Clinical periodontal measurements 
Subsequent to saliva and serum sampling, clinical periodontal recordings, 
including plaque index, PD, CAL, and bleeding on probing (BOP) (+/-) were performed 
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at 6 sites (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual and disto-
lingual locations) on each tooth present, except the third molars, using a Williams 
periodontal probe. CAL was assessed from the cement enamel junction to the base of the 
probable pocket. BOP (deemed positive if it occurred within 15 seconds after periodontal 
probing) was recorded dichotomously by visual examination. All measurements were 
performed by two precalibrated examiners. Inter-examiner and intra-examiner calibration 
was analyzed using the Kappa-Cohen test. The initial intraexaminer kappa values were 
0.96 (PD) and 0.86 (CAL) for PG and 0.93 (PPD) and 0.79 (CAL) for NN. The 
interexaminer values were 0.92 (PD) and 0.75 (CAL). 
 
5.3.4 Total RNA isolation 
Subgingival plaque samples stored in RNA Later were centrifuged at 16,100 g to 
collect whole cells. Cell pellets were resuspended in 1 ml RNA Bee and transferred to a 
bead-beating tube. Cells were lysed by bead-beating 3 times for 60 s and incubating on 
ice 1 m in between each bead beating. Lysed cell solutions were transferred to new 
microcentrifuge tubes, 200 µl chloroform was added. Tubes were shaken vigorously for 1 
m to mix, and incubated 5 m in an ice bath. Samples were centrifuged at 13,100 g for 30 
m at 4 °C to separate aqueous and organic phases. The aqueous phase from each sample 
was transferred to a new microcentrifuge tube and RNA was precipitated with an equal 
volume of isopropanol and 2 µg linear acrylamide for 16 h at -80°C. Samples were 
thawed in an ice bath and centrifuged for 30 m at 13,100 g at 4°C. Supernatants were 
removed, and RNA pellets were washed with twice with ice-cold 75 % ethanol by 
resuspension and centrifugation for 10 m at 16,100 g at 25°C. Following the second 
ethanol wash, RNA pellets were air-dried 5 m at 25°C and resuspended in 22 µl RNase-
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free water. RNA concentrations for each sample were determined with a Nanodrop 
spectrophotometer (Thermo Scientific).  
 
5.3.5 qrRNA-seq 
qrRNA-seq was developed by modifying 2 protocols from previous studies which 
sequenced bacterial 16S rDNA [203, 204]. Total subgingival plaque RNA for all 10 
healthy and diseased samples was used to reverse transcribe 16S cDNA with SSII reverse 
transcriptase (Invitrogen) and the universal bacterial 16S 926 RT gene-specific primer 
(Table 5.6) which anneals immediately downstream of the 16S rRNA V5 variable region. 
Negative control reactions lacking SSII were conducted on all RNA samples in parallel to 
ensure that DNA was not co-purified with the total RNA. From each RT reaction, 
including negative control reactions, 2 µl were removed and cDNA was used as template 
to minimally PCR amplify the 16S rRNA V4/V5 variable region using indexed sample-
specific primers 16SV5926R-BC0 through 16SV5926R-BC19 and the common primer 
16SV4515F (Table 5.6). All RT-PCR reaction products were separated by agarose gel 
electrophoresis, stained with ethidium bromide, and viewed with a GBox imaging 
system. Distinct cDNA bands were visible for all positive control reactions, while 
negative control reactions lacking RT showed no product, verifying the absence of DNA 
contamination in the original RNA preparations. Paired end 250 bp sequencing was 
performed on the 16S cDNA libraries using an Illumina MiSeq at the University of Texas 
Genomic Sequencing and Analysis Facility (UTGSAF) with custom MiSeq16SV4515F 
forward, MiSeq16SV5926R reverse, and MiSeq16SV4V5Index index sequencing 
primers (Table 5.6).  
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Table 5.6 Primer information. 
Primer name Sequence Sample 
16S926RT CCGTCAATTYYTTTRAGTTT  
16SV4515F AATGATACGGCGACCACCGAGATCTACACTATGGTAATTGTGTGC
CAGCMGCCGCGGTAA 
 
16SV5926R-BC0 CAAGCAGAAGACGGCATACGAGATTCCCTTGTCTCCAGTCAGTCA
G CC CCGTCAATTYYTTTRAGTTT 
D1 
16SV5926R-BC1 CAAGCAGAAGACGGCATACGAGATACGAGACTGATTAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
D2 
16SV5926R-BC2 CAAGCAGAAGACGGCATACGAGATGCTGTACGGATTAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT 
D3 
16SV5926R-BC3 CAAGCAGAAGACGGCATACGAGATATCACCAGGTGTAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT 
D4 
16SV5926R-BC4 CAAGCAGAAGACGGCATACGAGATTGGTCAACGATAAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
D5 
16SV5926R-BC5 CAAGCAGAAGACGGCATACGAGATATCGCACAGTAAAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
D6 
16SV5926R-BC6 CAAGCAGAAGACGGCATACGAGATGTCGTGTAGCCTAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
D7 
16SV5926R-BC7 CAAGCAGAAGACGGCATACGAGATAGCGGAGGTTAGAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT 
D8 
16SV5926R-BC8 CAAGCAGAAGACGGCATACGAGATATCCTTTGGTTCAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
D9 
16SV5926R-BC9 CAAGCAGAAGACGGCATACGAGATTACAGCGCATACAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
D10 
16SV5926R-BC10 CAAGCAGAAGACGGCATACGAGATACCGGTATGTACAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
H1 
16SV5926R-BC11 CAAGCAGAAGACGGCATACGAGATAATTGTGTCGGAAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
H2 
16SV5926R-BC12 CAAGCAGAAGACGGCATACGAGATTGCATACACTGGAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
H3 
16SV5926R-BC13 CAAGCAGAAGACGGCATACGAGATAGTCGAACGAGGAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
H4 
16SV5926R-BC14 CAAGCAGAAGACGGCATACGAGATACCAGTGACTCAAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
H5 
16SV5926R-BC15 CAAGCAGAAGACGGCATACGAGATGAATACCAAGTCAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
H6 
16SV5926R-BC16 CAAGCAGAAGACGGCATACGAGATGTAGATCGTGTAAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
H7 
16SV5926R-BC17 CAAGCAGAAGACGGCATACGAGATTAACGTGTGTGCAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
H8 
16SV5926R-BC18 CAAGCAGAAGACGGCATACGAGATCATTATGGCGTGAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
H9 
16SV5926R-BC19 CAAGCAGAAGACGGCATACGAGATCCAATACGCCTGAGTCAGTC
AG CC CCGTCAATTYYTTTRAGTTT  
H10 
MiSeq16SV4515F TATGGTAATTGTGTGCCAGCMGCCGCGGTAA  
MiSeq16SV5926R AGTCAGTCAGCCCCGTCAATTYYTTTRAGTTT  
MiSeq16SV4V5Index  AAACTYAAARRAATTGACGGGGCTGACTGACT  
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5.3.6 Bacterial population analyses 
The paired 250 bp forward and reverse MiSeq sequencing reads were assembled 
using fastq-join [219]. Qiime [209] was used to search the assembled 16S cDNA 
sequences from all 10 healthy and 10 diseased samples with Uclust against the 97% 
Greengenes reference database [208] for species-level identification of Operational 
Taxonomic Units (OTUs) using the Qiime python script pick_otus_through_otu_table.py. 
Prior to alpha diversity analyses, samples were rarefied, or sub-sampled, 10 times at each 
step from 500 to 5000 sequences with a 500-sequence step-size. Mean alpha diversity, or 
within sample diversity, was calculated using the Qiime python scripts alpha_diversity.py 
and collate_alpha.py to determine the number of observed species at each sub-sampling 
depth in the rarefication analysis. To determine the relative contributions of high 
abundance species to total diseased and healthy populations, unclassified and non-
specific OTUs assigned to bacteria were removed from each sample. Within each sample, 
abundances of OTUs were sorted from most to least abundant, and a running sum 
percentage of the total population was calculated for the addition of each additional 
species. Jackknifed beta-diversity, or between sample diversity, was determined for 5000 
sequences per sample using the Qiime python script jackknifed_beta_diversity.py. A 
multidimensional scaling (MDS) analysis plot was generated from the average of 10 
distance matrices determined by unweighted Unifrac analysis [220] calculated by the 
jackknifed_beta_diversity.py script and was used to determine the similarity between 
sample populations. Briefly, Unifrac analysis takes into account the number of shared and 
unique species between two populations, and provides a distance metric that represents 
the overall similarity of the two populations [220]. Healthy and disease centroids on the 
MDS plot were determined from the mean positions of the respective samples on the plot. 
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Euclidean distances were calculated to determine relatedness between paired healthy and 
diseased samples and from samples to their respective healthy or disease centroids. 
 
5.3.7 metaRNA-seq 
Patients 5, 6, and 8 were selected for total RNA sequencing to analyze microbial 
population gene expression in periodontal health and disease. Total RNA samples were 
treated with the RiboZero Epidemiology kit (Epicentre) to deplete bacterial and 
eukaryotic rRNA and purified by ethanol precipitation using 20 µg linear acrylamide to 
precipitate the RNA. Depleted RNA was fragmented with NEB RNA Fragmentation 
Buffer, according to the manufacturer’s protocol. Fragmented RNA was ethanol 
precipitated with linear acrylamide and eluted in RNase-free water. RNA-seq libraries 
were prepared using the NEB Next Multiplex Small RNA Library Prep Set for Illumina, 
according to the manufacturer’s protocol. The resulting strand-specific cDNA libraries 
were stained with SYBR gold nucleic acid stain (Invitrogen), visualized on a GBox 
imaging system, and cDNA between ~150-300 bp was extracted, corresponding to 
fragmented RNA between 31-181 nt. Gel extracted cDNA was eluted in NEB 
polyacrylamide gel elution buffer, ethanol precipitated, and resuspended in TE buffer 
(NEB). Libraries were quantified and analyzed using a Nanodrop spectrophotometer 
(Thermo Scientific) and a Bioanalyzer (Agilent). Single end 50 bp sequencing was 
conducted at the UTGSAF on an Illumina HiSeq2000 producing ~1.5 billion sequencing 
reads (Table 5.3). 
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5.3.8 metaRNA-seq fastq read processing 
HiSeq reads were trimmed with Flexbar [170], as described previously [221], to 
remove contaminating adapter sequences from the cDNA library preparation. Flexbar 
was run with settings to collect reads 15-50 bp following adapter trimming for further 
analysis, because these reads are specific: 15 bp sequences are predicted to occur 
randomly only once per ~1 billion bp. 
 
5.3.9 Determining origin of metatranscriptome sequencing reads 
All metatranscriptome data analysis was conducted on the Texas Advanced 
Computing Center Stampede supercomputer. Human oral bacteria genome sequences 
(oral_microbiome.na.zip, >4 billion bp) were downloaded from the Human Oral 
Microbiome Database [210] (HOMD) available on the world wide web via 
ftp://ftp.homd.org/human_oral_microbial_genomic_sequences/20130520/, the human 
RNA database (human.rna.fna.gz) was downloaded on the world wide web through 
NCBI RefSeq via ftp://ftp.ncbi.nlm.nih.gov/refseq/H_sapiens/mRNA_Prot/, and the viral 
genome database (viral.1.1.genomic.fna.gz, ~121 million bp) consisting of sequenced 
viruses and bacteriophage available was downloaded through NCBI RefSeq via 
ftp://ftp.ncbi.nih.gov/refseq/release/viral/. Reference sequences were indexed with 
Bowtie 2.0 [171]. Since the HOMD sequences exceeded the size limit for Bowtie 2.0 
[171], the sequences were split into two files with the custom Perl script FastaSplit.pl 
(http://github.com/khturner/metaRNA-seq) and then each file was indexed. Trimmed 
fastq sequencing reads were split into chunks of 10 million reads using the UNIX split 
command. Each read chunk was mapped separately to the four indexed references 
sequences using Bowtie 2.0 [171], keeping only 1 match for each fastq read for each 
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reference. Unmapped reads were discarded and mapped reads were labeled to indicate 
whether they mapped to either of the 2 human oral microbiome indexed databases 
(HOMD1 and HOMD2), the indexed human RNA database, or the indexed viral RNA 
database. The resulting labeled mapped reads in sam file format for each read chunk in 
each sample were concatenated and sorted by read name using the UNIX cat and sort 
commands. Since initially we were interested in whether a read was of bacterial origin, 
human origin, or viral origin, if a single fastq read mapped to both HOMD1 and 
HOMD2, the read mapped to HOMD2 was discarded; however, if a read mapped to 
multiple references (e.g. HOMD and human) it was labeled in the file using the custom 
Perl script MatchMarker.pl (http://github.com/khturner/metaRNA-seq). The number of 
uniquely mapping reads and reads mapping to multiple reference databases for each 
sample was determined using the UNIX uniq and pattern-matching grep commands. 
 
5.3.10 Generating a reference metagenome for differential gene expression analysis 
 Genomes for differential gene expression analyses were selected using 16S rRNA 
sequencing for patients 5, 6, and 8. Reference genome sequences and annotations were 
downloaded in Fasta and GFF formats, respectively. Genomes were downloaded, 
concatenated, and processed to only include protein-coding genes using the custom Perl 
scripts GenomeMerge.pl and HOMDpull.sh (http://github.com/khturner/metaRNA-seq) 
to generate a metagenome to serve as a reference. Individual genome sequences and 
annotations were obtained from NCBI Genbank (ftp://ftp.ncbi.nih.gov/genbank) and 
HOMD (http://www.homd.org/index.php?&name=seqDownload&type=G). When 
available, EC numbers for genes were downloaded from the Kyoto Encyclopedia of 
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Genes and Genomes (KEGG) [213] using the custom Perl scripts PullEC.pl and 
HOMD_GenomeMerge.pl (http://github.com/khturner/metaRNA-seq). 
 
5.3.11 Differential gene expression analyses 
Trimmed RNA-seq reads produced by Flexbar27 were mapped against the indexed 
reference metagenome and reads mapping to each gene were counted using the custom 
UNIX shell script MapCount_RNASeq.sh (http://github.com/khturner/metaRNA-seq), 
which depends on Bowtie 2.0 [171] and the Python package HTSeq 
(https://pypi.python.org/pypi/HTSeq). The trimmed sequencing reads are read into the 
script, mapped to the metagenome, and the number of reads in each sample mapping to 
each annotated gene in the metagenome are counted. Paired differential gene expression 
was determined using the custom UNIX shell script calcRNASeqPaired.sh 
(http://github.com/khturner/metaRNA-seq), which depends on the R package edgeR29 and 
the supporting R script Pairwise_edgeR.r (http://github.com/khturner/metaRNA-seq). 
This analysis normalizes read counts between samples, fits the data to a negative 
binomial distribution, and determines pairwise differential expression using the patient-
matched samples. 
 
5.3.12 Differential expression analysis of KEGG enzymes 
EC numbers obtained from HOMD and the KEGG databases were added to the 
table containing raw read counts per gene produced by MapCount_RNASeq.sh (above). 
Genes lacking EC numbers were removed from the table and the table was sorted by the 
EC numbers. The total number of reads mapping to each EC number was calculated 
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using the custom Perl script ECcounter.pl (http://github.com/khturner/metaRNA-seq), to 
produce a table containing number of reads mapping to each EC number in each sample. 
Differential expression of EC enzymes was determined using the custom UNIX shell 
script Pairwise_edgeR.sh (http://github.com/khturner/metaRNA-seq), which depends on 
the R package edgeR [222] and the supporting R script Pairwise_edgeR.r 
(http://github.com/khturner/metaRNA-seq). 
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Chapter 6. Discussion 
The beginning of this dissertation focused on characterizing genetic regulatory 
mechanisms and examining the evolutionary history of the opportunistic pathogen 
A. actinomycetemcomitans. Using directed molecular probing of non-coding RNAs and 
whole transcriptome profiling, I described numerous genetic regulatory mechanisms 
employed by A. actinomycetemcomitans to respond to its environment. I also showed that 
the evolutionary history of A. actinomycetemcomitans is tightly linked to natural 
transformation and CRISPR genome defense. Through transcriptional profiling, I 
provided the first comprehensive view of A. actinomycetemcomitans transcription and 
determined the importance of oxygen-independent metabolism for survival in vivo. 
 
This dissertation work culminated in the examination of community behavior of 
the oral microbiome in health and disease. This study showed for the first time that the 
microbiome differentially regulates gene expression during disease. Transcriptional 
profiling of individual community members showed that metabolic gene expression 
changes in a single species might prolong disease. Together these data suggest that 
keystone species may not influence polymicrobial disease through “traditional” virulence 
factors, like toxins, but do so through basic metabolic processes that are impacted by 
other community members. 
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6.1 A. ACTINOMYCETEMCOMITANS GENE REGULATION AND EVOLUTION 
 
6.1.1 Switching off expression: knowing when enough is enough 
Using Northern blot analysis I discovered the first ncRNAs in 
A. actinomycetemcomitans. During these studies I characterized a new class of bacterial 
lysine-specific transporter, encoded by the widespread lysT gene. Northern blot analyses 
showed that lysT is transcriptionally regulated by a lysine riboswitch. The riboswitch 
functions by shutting down lysT expression at a threshold intracellular lysine 
concentration. This mechanism theoretically allows A. actinomycetemcomitans and other 
organisms to divert resources from lysT expression to other necessities once enough 
lysine has been acquired from the environment. This study also opens up the possibility 
that other putative NhaC-type transporters have roles beyond sodium and hydrogen 
transport. 
 
6.1.2 A CRISPR view of A. actinomycetemcomitans evolution 
Phylogenetic characterization of A. actinomycetemcomitans showed that its 
evolution is linked to natural transformation. These analyses provide strong evidence 
that, in the case of A. actinomycetemcomitans, natural transformation is under selection 
due to its effect on genetic expansion. This hypothesis is based on the loss of competence 
genes throughout A. actinomycetemcomitans evolution, followed by the inactivation of 
CRISPR genome defense systems. Non-competent strains were consequently more 
vulnerable to minor genetic expansion by acquiring mobile genetic elements. In contrast, 
competent strains experienced continued genetic variation through both genome 
expansion and gene rearrangement.   
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Figure 6.1 Navigating the genomic fitness landscape through genome expansion and 
reduction. 
Non-competent A. actinomycetemcomitans strains constantly arise in competent 
populations throughout evolution; however, non-competent strains only persist when near 
fitness peaks (red circle) and are otherwise outcompeted by competent strains away from 
fitness peaks (yellow X's). The evolution of competent strains (green circle, green line) 
through genomic rearrangements and acquisition of new genes (Fig. 3.2) leads to 
speciation, as competent strains can explore the fitness landscape to a greater extent than 
non-competent strains. The loss of CRISPR-cas allows non-competent bacteria to acquire 
new genes through bacteriophage and plasmids to ascend local fitness peaks (red line). In 
this context, genotype refers to genome content including mutations, new genes, and 
rearrangements. 
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The evolutionary connection between natural transformation and CRISPR 
immunity highlights a balancing act between genome expansion and reduction (Fig. 6.1). 
We propose a model wherein natural transformation permits exploration of a genomic 
fitness landscape through the acquisition of new genetic material. Near fitness peaks, 
selection for exploration through transformation may be weakened, and competence 
genes can be lost to inactivating mutations. However, due to new selective pressures, 
genome expansion through mobile genetic elements is favored, and inactivating CRISPR 
mutations arise. Long-term in vitro evolution studies could be designed to test this theory.  
 
6.1.3 A. actinomycetemcomitans behavior in vivo 
Transcriptional profiling revealed that fermentation and anaerobic respiration 
impact A. actinomycetemcomitans survival in the murine abscess infection. While 
A. actinomycetemcomitans possesses multiple fermentative and anaerobic respiratory 
pathways, two specific operons, frdABCD and fdhF1F2, were up-regulated in vivo and 
mutants in these operons had impaired fitness (Fig. 4.5). This study provided a 
comprehensive transcriptional map for A. actinomycetemcomitans in vivo and in a single 
species biofilm, as I identified 691 transcriptional start sites and 210 ncRNAs. Among the 
putative ncRNAs identified, 80 were differentially regulated in vivo, suggesting that they 
may play important roles in the host environment. In addition to providing insight into 
the genetic regulatory mechanisms mediating persistence in vivo, this study also lays an 
essential foundation for studying gene expression changes impacting synergistic 
polymicrobial infections.  
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6.1.4 Future directions 
One of the primary goals of this dissertation was to develop a foundation in 
A. actinomycetemcomitans gene regulation that could be used to define genes and 
regulatory networks underlying polymicrobial synergy. Because 
A. actinomycetemcomitans and S. gordonii exhibit synergy in a mixed species infection, 
the obvious next step in these studies is to use RNA-seq to transcriptionally profile 
A. actinomycetemcomitans and S. gordonii murine abscess co-infections. Since apiA and 
katA genes were up-regulated by hydrogen peroxide and S. gordonii in vitro [16], we 
anticipate that these genes will be up-regulated in co-infections as well. These genes 
should serve as controls. Using RNA-seq we will identify global changes in gene 
expression in addition to katA and apiA that likely contribute to polymicrobial fitness. 
 
To begin defining gene regulation mediating synergy in co-infections, I have 
analyzed A. actinomycetemcomitans gene expression in co-culture biofilms and murine 
abscess co-infections with S. gordonii. In these preliminary analyses 
A. actinomycetemcomitans up-regulates expression of both apiA and katA in the presence 
of S. gordonii, as expected (Fig. 6.2AB). However, these genes were up-regulated to a 
lesser extent in vivo than in vitro. In a single species infection, A. actinomycetemcomitans 
expressed genes involved in anaerobic metabolism, suggesting limited oxygen 
availability. Since hydrogen peroxide is produced by S. gordonii in an oxygen-dependent 
manner, and katA and apiA are induced by S. gordonii-produced hydrogen peroxide, 
these results could be explained by the reduced availability of oxygen in the abscess 
relative to the biofilm.  
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Figure 6.2 Differential gene regulation of A. actinomycetemcomitans in vitro and 
in vivo during growth with S. gordonii. 
(A) Gene expression of A. actinomycetemcomitans during co-culture biofilm growth with 
S. gordonii in vitro. A. actinomycetemcomitans was grown with S. gordonii in colony 
biofilms grown on a solid glucose defined medium and gene expression was compared to 
single species biofilms using RNA-seq as described in Chapter 4 (n = 2). (B) Gene 
expression of A. actinomycetemcomitans during murine abscess co-infection with 
S. gordonii. A. actinomycetemcomitans and S. gordonii were co-incoulated into abscesses 
as described previously [22]. RNA was isolated from abscesses at 3 days post-infection 
and gene expression was compared to single species infections using RNA-seq, as 
described in Chapter 4 (n = 3). In both A and B, blue points indicate katA and apiA, and 
red points indicate significant gene expression changes in co-culture (P < 0.05, DESeq).  
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Only one other protein-coding gene, the putative xylose transport gene xylF, was 
commonly up-regulated during growth with S. gordonii in vitro and in vivo. This 
observation is interesting considering that the A. actinomycetemcomitans strain used in 
our RNA-seq experiments was a serotype A strain, and serotype A strains are incapable 
of fermenting xylose [223]. Furthermore, xylose is a sugar commonly found in plants and 
not produced in the oral cavity. This result has several implications. First, it may indicate 
that xylose fermentation was once important for polymicrobial interactions in ancestral 
environmental relatives of A. actinomycetemcomitans, but throughout the course of 
evolution selective pressures maintaining active xylose fermentation genes have 
weakened. Second, it suggests that certain strains have experienced selective pressure to 
maintain xylose fermentation systems. If so, these strains would only encounter xylose 
from dietary sources. Either way, these results suggest that in the presence of 
streptococci, A. actinomycetemcomitans increases xylose transport. S. gordonii does not 
ferment xylose, so this may represent another way that A. actinomycetemcomitans avoids 
competition for carbon sources with faster-growing community members. 
 
RNA-seq provides a global view of gene expression and can be used to identify 
genes impacting fitness. However, the results obtained from RNA-seq are dependent on 
the choice of control conditions, and genes impacting fitness that are not differentially 
regulated may be overlooked by this technique. Transposon sequencing (Tn-seq) is a 
complementary approach to RNA-seq that can be used to define genome-wide fitness 
determinants [224]. The technique utilizes a saturating transposon mutant library and 
high-throughput sequencing to identify mutants that are less fit under a chosen selective 
condition. Tn-seq requires a saturating transposon mutant library. This library should 
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contain a pool of individual insertion mutants, representing unique mutants for every 20 
bp in the genome. An A. actinomycetemcomitans Tn-seq library should have ~100,000 
unique mutants. The abundance of mutants in this library can be determined by 
sequencing transposon adjacent DNA before and after exposure to a selective condition. 
RNA-seq can be used to identify differentially expressed genes in co-infection, while 
Tn-seq can be used to measure mutant fitness independent of expression changes. 
Combining Tn-seq with RNA-seq can therefore provide powerful comprehensive 
information about a polymicrobial infection. 
 
Studying pairwise interactions will inform us about genes impacting synergy in 
polymicrobial infections, but ultimately it will be important to examine behavior within 
more complex communities. One study used metatranscriptomics to examine 
transcription within defined in vitro oral microbial communities composed of 
“commensals” and “commensals and pathogens;” however, this study was limited by the 
experimental design, which focused only on “commensal” gene expression [225]. Here I 
propose a step-wise additive approach for studying polymicrobial communities: microbes 
should first be studied in pairwise combinations, and then more complex interactions can 
be explored by adding organisms one at a time to the community. This approach will 
allow the precise definition of the effects each organism has on the community. 
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6.2 IMPLICATIONS FOR GENE EXPRESSION CHANGES IN THE MICROBIOME 
 
6.2.1 Gene expression of the oral microbiome 
Using qrRNA-seq and metaRNA-seq, I demonstrated that periodontitis is 
characterized by changes in microbial population structure, as well as differential gene 
expression at the community level and within individual species (Fig. 5.1-5.6, 
Table 5.5.). Specifically, diseased microbial populations adopted a similar composition 
that was less diverse than healthy oral microbial populations (Fig. 5.2). A few highly 
abundant organisms dominated diseased populations, whereas many low abundance 
species comprised healthy populations. As a community, gene expression changes 
revealed a shift toward amino acid consumption. This metabolic shift was paired with 
increases in the expression of proteases, which are important virulence factors. Many of 
the community gene expression changes could be attributed to T. forsythia and 
F. nucleatum. While T. forsythia ribosomal content increased during disease, 
F. nucleatum remained equally abundant within the community. This suggests that 
F. nucleatum expression changes were due to differential gene regulation rather than 
mere changes in abundance. A consequence of differential gene expression in 
F. nucleatum was the increase in lysine fermentative gene expression. Lysine 
fermentation by F. nucleatum produces the oral inflammatory molecule butyrate [226]. 
Since butyrate arrests fibroblast cell growth and likely delays wound healing [218], we 
propose that F. nucleatum is a keystone species in the diseased periodontal microbial 
community. 
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6.2.2 Future directions 
These pilot studies revealed microbial behaviors that likely play important roles in 
oral disease progression. However, a key question remains unanswered. Are changes in 
microbial behavior a cause or consequence of periodontitis? While this question is 
difficult to answer, careful experimental design may provide a way to get at the root of 
the problem in periodontal disease. A multifacteted approach combining bacterial 
ecology, bacterial genetics, and host genetics showed that P. gingivalis-induced murine 
periodontitis was dependent on specific host and P. gingivalis genes, as well as the 
commensal microbiota [214]. A similar approach could be used to test the role of 
F. nucleatum butyrate production in periodontal disease. An alternate approach would be 
to use metaRNA-seq to characterize different stages of periodontal disease. A variety of 
patient plaque samples from healthy, moderate, and severe periodontal pockets would 
need to be collected for analyses. If gene microbial gene expression changes are observed 
in moderate pockets before the onset of fully developed periodontitis, one could conclude 
that microbial gene expression changes are leading to disease. However, if the opposite is 
true, and fully developed periodontitis precedes changes in the microbiota, then other 
factors likely lead to disease. 
 
It will be interesting to compare microbial community compositions and behavior 
in different types of periodontal disease. Periodontitis is a general term that describes 
several different diseases. We used metaRNA-seq to analyze gene expression in 
aggressive periodontitis in adults. Aggressive periodontitis in adolescents is one major 
form of periodontal disease and is typically associated with A. actinomycetemcomitans. 
Because we have studied A. actinomycetemcomitans polymicrobial interactions in vitro 
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and in murine abscess infections, metaRNA-seq provides a complementary tool to test 
the hypotheses we developed about polymicrobial infections using streptococci. In 
contrast, chronic periodontitis is more commonly associated with P. gingivalis, 
T. denticola, and T. forsythia [19]. Applying metaRNA-seq to study these infections will 
help test hypotheses about these disease processes, specifically how they relate to each 
other, how they differ, and the potential roles the microbes play in these diseases. 
 
Finally, metaRNA-seq is a powerful tool that can be applied to study any 
microbial community. Potential applications for metaRNA-seq include studying other 
microbiome-mediated diseases, diseases caused by invasive pathogens, or microbial 
communities in the environment. The gut microbiome has been of extreme interest due to 
population shifts that have been associated with obesity, diabetes, and Crohn’s disease 
[199-202]. Using metaRNA-seq to study gut microbial gene expression in healthy and 
sick patients will help determine which specific microbial processes are actively 
contributing to these ailments. A similar approach to metaRNA-seq has been used to 
study microbial gene expression patterns in ocean sediment, revealing microbial 
contributions to biogeochemical cycles [227]. This tool could also be used to study the 
impacts of pollution on different ecosystems. For instance, differences have been 
observed in microbiota populating healthy and diseased coral [228], and metaRNA-seq 
analyses of these microbial communities may lend insight into reef bleaching. Thoughtful 
experimental design will allow researchers to use metaRNA-seq to address many open 
questions in the fields of microbial ecology and pathogenesis.  
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